var title_f32_31_33264="Scopolamine: Drug information";
var content_f32_31_33264=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Scopolamine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12618171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/58/24484?source=see_link\">",
"       Scopolamine (ophthalmic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32375?source=see_link\">",
"       Scopolamine (systemic): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9879 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33264=[""].join("\n");
var outline_f32_31_33264=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?23/58/24484?source=related_link\">",
"      Scopolamine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32375?source=related_link\">",
"      Scopolamine (systemic): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_31_33265="Derivation great vessels";
var content_f32_31_33265=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Origin of great vessels and ductus arteriosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 424px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown is the morphologic derivation of proximal pulmonary and aortic vessels at birth. The main pulmonary artery (MPA) comes from the fused ventral VIth arterial arch (FV-VI) while the right (RPA) and left pulmonary arteries (LPA) come from the right (RV-VI) and left ventral VIth arterial arches (LV-VI). The ascending aorta (AAo) and right brachiocephalic artery (RBCA) are derived from the right ventral IVth arterial arch (RV-IV), while the aortic arch (Ao arch) comes from the left ventral IVth arterial arch (LV-IV). The ductus arteriosus (DA) is derived from the left dorsal VIth arch (LD-VI).",
"    <div class=\"footnotes\">",
"     LSA: left subclavian artery; LCA: left carotid artery; RSA: right subclavian artery; RCA: right carotid artery.",
"    </div>",
"    <div class=\"reference\">",
"     With permission from Skidmore, FD, Ann R Coll Surg Engl 1975; 57:186.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33265=[""].join("\n");
var outline_f32_31_33265=null;
var title_f32_31_33266="Contents: Pediatric neurology";
var content_f32_31_33266=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric neurology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric neurology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cerebral palsy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/33/29209\">",
"           Clinical features of cerebral palsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/0/4104\">",
"           Diagnosis and classification of cerebral palsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/50/41768\">",
"           Epidemiology and etiology of cerebral palsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/37/15962\">",
"           Management and prognosis of cerebral palsy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cerebrovascular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/11/31930\">",
"           Cerebrovascular complications of sickle cell disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/26/7594\">",
"           Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/31/31226\">",
"           Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/61/23513\">",
"           Ischemic stroke in children and young adults: Etiology and clinical features",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/37/43608\">",
"           Ischemic stroke in children: Evaluation, initial management, and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/27/27063\">",
"           Ischemic stroke in children: Secondary prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/44/3786\">",
"           Moyamoya disease: Etiology, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/36/7751\">",
"           Moyamoya disease: Prognosis and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27690\">",
"           Stroke in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/16/9482\">",
"           Treatment and prognosis of cerebral venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/9/18584\">",
"           Vascular malformations of the central nervous system",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Demyelinating disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/52/25416\">",
"           Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/22/20838\">",
"           Acute disseminated encephalomyelitis in children: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/58/40872\">",
"           Alexander disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/4/34888\">",
"           Cerebrotendinous xanthomatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/20/1352\">",
"           Differential diagnosis of acute central nervous system demyelination in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/15/9464\">",
"           Optic neuritis: Pathophysiology, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/15/29944\">",
"           Optic neuritis: Prognosis and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/32/12809\">",
"           Pathogenesis, clinical features, and diagnosis of pediatric multiple sclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/9/13465\">",
"           Pelizaeus-Merzbacher disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/53/35671\">",
"           Sj������gren-Larsson syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/32/21000\">",
"           Treatment and prognosis of pediatric multiple sclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/31/38392\">",
"           Vanishing white matter disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Developmental and behavioral problems",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/20/15689\">",
"           Asperger disorder: Clinical features and diagnosis in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/52/41801\">",
"           Asperger disorder: Management and prognosis in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/18/26922\">",
"           Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/61/32730\">",
"           Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/1/4122\">",
"           Autism spectrum disorders in children and adolescents: Behavioral and educational interventions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/54/16234\">",
"           Autism spectrum disorders in children and adolescents: Complementary and alternative therapies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/54/872\">",
"           Autism spectrum disorders in children and adolescents: Overview of management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/46/35562\">",
"           Autism spectrum disorders in children and adolescents: Pharmacologic interventions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/41/664\">",
"           Clinical features of autism spectrum disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/33/29209\">",
"           Clinical features of cerebral palsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/3/38969\">",
"           Diagnosis of autism spectrum disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/10/26793\">",
"           Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/8/5257\">",
"           Intellectual disability (mental retardation) in children: Evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/59/40887\">",
"           Intellectual disability (mental retardation) in children: Management; outcomes; and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/57/32665\">",
"           Specific learning disabilities in children: Clinical features",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/27/37306\">",
"           Specific learning disabilities in children: Educational management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/6/35944\">",
"           Specific learning disabilities in children: Evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/18/44329\">",
"           Specific learning disabilities in children: Role of the primary care provider",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Encephalopathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/52/25416\">",
"           Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/62/22506\">",
"           Acute toxic-metabolic encephalopathy in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/24/2442\">",
"           Clinical features, diagnosis, and treatment of neonatal encephalopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/14/30953\">",
"           Etiology and pathogenesis of neonatal encephalopathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Evaluation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/40/23178\">",
"           Approach to neuroimaging in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/13/34004\">",
"           Approach to the infant with hypotonia and weakness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/17/14618\">",
"           Detailed neurologic assessment of infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/2/30761\">",
"           Diagnosis of brain death",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/54/3946\">",
"           Etiology and evaluation of macrocephaly in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/30/28136\">",
"           Evaluation of stupor and coma in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/1/25625\">",
"           Lumbar puncture: Indications, contraindications, technique, and complications in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/5/19544\">",
"           Treatment and prognosis of coma in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Feeding the child",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/30/15850\">",
"           The ketogenic diet",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genetic disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/56/33673\">",
"           Adrenoleukodystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/6/7274\">",
"           Clinical features and diagnosis of the mucopolysaccharidoses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/16/35082\">",
"           Complications and management of the mucopolysaccharidoses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/31/31226\">",
"           Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/25/8599\">",
"           Huntington disease: Genetics and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/60/4038\">",
"           Krabbe disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/27/42421\">",
"           Metachromatic leukodystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/12/7370\">",
"           Mitochondrial myopathies: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/30/2536\">",
"           Mitochondrial myopathies: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/35/12853\">",
"           Mitochondrial structure, function, and genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/49/27414\">",
"           Neurologic manifestations of Fabry disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/46/7914\">",
"           Organic acidemias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/0/20489\">",
"           Overview of Niemann-Pick disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/23/8570\">",
"           Peroxisomal disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/29/32218\">",
"           Rett syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/9/8344\">",
"           Spinal muscular atrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/39/4727\">",
"           Sturge-Weber syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/48/14088\">",
"           Tests used in the diagnosis of Wilson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/0/24586\">",
"           The genodermatoses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/11/23737\">",
"           Treatment of Wilson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/38/34410\">",
"           Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/36/32328\">",
"           Tuberous sclerosis complex: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/9/18584\">",
"           Vascular malformations of the central nervous system",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Headache",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/8/35977\">",
"           Approach to the child with headache",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/44/44743\">",
"           Basilar-type migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/21/42327\">",
"           Classification of migraine in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/48/34568\">",
"           Cyclic vomiting syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/37/44633\">",
"           Elevated intracranial pressure in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/3/18490\">",
"           Management of migraine headache in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/8/15496\">",
"           Migrainous vertigo",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/25/8600\">",
"           Pathophysiology, clinical features, and diagnosis of migraine in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/59/34744\">",
"           Tension-type headache in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/16/21769\">",
"           Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/18/23848\">",
"           Acute viral encephalitis in children and adolescents: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/51/14135\">",
"           Clinical manifestations and diagnosis of Rocky Mountain spotted fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/21/10586\">",
"           Viral meningitis: Clinical features and diagnosis in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Malformations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/62/11237\">",
"           Anencephaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/4/26697\">",
"           Chiari malformations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/54/5994\">",
"           Hydrocephalus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/14/19688\">",
"           Orthopedic issues in myelomeningocele (spina bifida)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/46/26344\">",
"           Overview of the management of myelomeningocele (spina bifida)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/27/20921\">",
"           Pathogenesis and types of occult spinal dysraphism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/62/33767\">",
"           Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/57/3991\">",
"           Primary (congenital) encephalocele",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/59/15288\">",
"           Urinary tract complications of myelomeningocele (spina bifida)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/48/34568\">",
"           Cyclic vomiting syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/0/17417\">",
"           Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/25/15769\">",
"           Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/54/41833\">",
"           Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/32/12809\">",
"           Pathogenesis, clinical features, and diagnosis of pediatric multiple sclerosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Movement disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/26/8616\">",
"           Acquired torticollis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/34/10790\">",
"           Acute cerebellar ataxia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/60/23497\">",
"           Ataxia-telangiectasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/36/15943\">",
"           Bradykinetic movement disorders in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/45/13018\">",
"           Clinical manifestations, diagnosis, and natural history of Wilson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/49/43798\">",
"           Congenital muscular torticollis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/37/13910\">",
"           Epidemiology and pathogenesis of Wilson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/4/15432\">",
"           Friedreich ataxia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/40/18058\">",
"           Hyperkinetic movement disorders in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/35/37433\">",
"           Overview of the hereditary ataxias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/50/32554\">",
"           Restless legs syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/31/22007\">",
"           Sydenham chorea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/35/29242\">",
"           The spinocerebellar ataxias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/8/22664\">",
"           Tourette syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neonatal neurology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/53/2906\">",
"           Brachial plexus syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/11/6328\">",
"           Clinical features and electrodiagnosis of neonatal seizures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/44/42697\">",
"           Clinical manifestations and diagnosis of intraventricular hemorrhage in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/6/13417\">",
"           Congenital myopathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/14/30953\">",
"           Etiology and pathogenesis of neonatal encephalopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/23/41335\">",
"           Etiology and prognosis of neonatal seizures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/46/31465\">",
"           Management and complications of intraventricular hemorrhage in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/60/35783\">",
"           Neonatal epileptic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/10/166\">",
"           Neuromuscular junction disorders in newborns and infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/48/11015\">",
"           Overview of peripheral nerve and muscle disorders causing hypotonia in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/7/33913\">",
"           Periventricular leukomalacia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/42/12970\">",
"           Pneumococcal meningitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27690\">",
"           Stroke in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/0/13\">",
"           Treatment of neonatal seizures",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurocutaneous disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/50/36650\">",
"           Neurofibromatosis type 1 (von Recklinghausen's disease)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/39/4727\">",
"           Sturge-Weber syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/38/34410\">",
"           Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/36/32328\">",
"           Tuberous sclerosis complex: Management",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neuromuscular disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/56/905\">",
"           Approach to the metabolic myopathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/36/21065\">",
"           Causes of metabolic myopathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/16/1290\">",
"           Clinical features and diagnosis of Duchenne and Becker muscular dystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/58/21415\">",
"           Emery-Dreifuss muscular dystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/63/6134\">",
"           Energy metabolism in muscle",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/34/26153\">",
"           Facioscapulohumeral muscular dystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/32/15881\">",
"           Limb-girdle muscular dystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/26/19882\">",
"           Myotonic dystrophy: Etiology, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/40/18057\">",
"           Myotonic dystrophy: Prognosis and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/10/166\">",
"           Neuromuscular junction disorders in newborns and infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/14/41192\">",
"           Oculopharyngeal, distal, and congenital muscular dystrophies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/3/27705\">",
"           Overview of Guillain-Barr������ syndrome in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/43/29368\">",
"           Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/35/31287\">",
"           Pathogenesis of myasthenia gravis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/33/32276\">",
"           Patient information: Overview of muscular dystrophies (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/9/8344\">",
"           Spinal muscular atrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/5/2138\">",
"           Treatment and prognosis of juvenile dermatomyositis and polymyositis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/2/26666\">",
"           Treatment of Duchenne and Becker muscular dystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/51/41781\">",
"           Treatment of Guillain-Barr������ syndrome in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neuropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/42/25257\">",
"           Facial nerve palsy in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/37/602\">",
"           Hereditary neuropathies associated with generalized disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/59/35770\">",
"           Hereditary primary motor sensory neuropathies, including Charcot-Marie-Tooth disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/16/43272\">",
"           Hereditary sensory and autonomic neuropathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/60/4038\">",
"           Krabbe disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/27/42421\">",
"           Metachromatic leukodystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/49/27414\">",
"           Neurologic manifestations of Fabry disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/0/20489\">",
"           Overview of Niemann-Pick disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/20/33098\">",
"           Overview of acquired peripheral neuropathies in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/24/21895\">",
"           Overview of hereditary neuropathies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ophthalmology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/44/12999\">",
"           Fourth cranial nerve (trochlear nerve) palsy in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/32/32262\">",
"           Horner's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/15/20726\">",
"           Myopathies affecting the extraocular muscles in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/15/9464\">",
"           Optic neuritis: Pathophysiology, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/15/29944\">",
"           Optic neuritis: Prognosis and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/0/1034\">",
"           Pendular nystagmus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/2/43046\">",
"           Sixth cranial nerve (abducens nerve) palsy in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/8/28806\">",
"           Supranuclear disorders of gaze in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/34/40487\">",
"           Third cranial nerve (oculomotor nerve) palsy in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Seizures",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/57/921\">",
"           Benign partial epilepsies of childhood",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/4/14409\">",
"           Clinical and laboratory diagnosis of seizures in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/28/18888\">",
"           Clinical features and complications of status epilepticus in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/2/1063\">",
"           Clinical features and diagnosis of infantile spasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/11/6328\">",
"           Clinical features and electrodiagnosis of neonatal seizures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/62/33769\">",
"           Epilepsy syndromes in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/15/1273\">",
"           Etiology and pathogenesis of infantile spasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/23/41335\">",
"           Etiology and prognosis of neonatal seizures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/9/3226\">",
"           Febrile seizures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/30/15849\">",
"           Juvenile myoclonic epilepsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/1/23578\">",
"           Localization-related (partial) epilepsy: Causes and clinical features",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/28/30154\">",
"           Management and prognosis of infantile spasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/50/30505\">",
"           Management of status epilepticus in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/60/35783\">",
"           Neonatal epileptic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/31/29175\">",
"           Nonepileptic paroxysmal disorders in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/51/24376\">",
"           Nonepileptic paroxysmal disorders in infancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/25/21912\">",
"           Overview of the classification, etiology, and clinical features of pediatric seizures and epilepsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/32/37386\">",
"           Overview of the treatment of seizures and epileptic syndromes in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/32/37385\">",
"           Pathophysiology of seizures and epilepsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/61/43994\">",
"           Pharmacology of antiepileptic drugs",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/0/13\">",
"           Treatment of neonatal seizures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/7/19578\">",
"           Vagus nerve stimulation therapy for the treatment of epilepsy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Trauma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/13/32985\">",
"           Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/19/40249\">",
"           Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/35/10808\">",
"           Intracranial epidural hematoma in children: Clinical features, evaluation, and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/61/11222\">",
"           Intracranial epidural hematoma in children: Epidemiology, anatomy and pathophysiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/49/29464\">",
"           Intracranial subdural hematoma in children: Clinical features, evaluation, and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/4/21575\">",
"           Intracranial subdural hematoma in children: Epidemiology, anatomy, and pathophysiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/38/12906\">",
"           Minor head trauma in infants and children",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-772F5318CB-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f32_31_33266=[""].join("\n");
var outline_f32_31_33266=null;
var title_f32_31_33267="Menthol and zinc oxide (topical): Patient drug information";
var content_f32_31_33267=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Menthol and zinc oxide (topical): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/43/44722?source=see_link\">",
"     see \"Menthol and zinc oxide (topical): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F15573799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Calmoseptine&reg; [OTC];",
"     </li>",
"     <li>",
"      Remedy&reg; Calazime&reg; [OTC];",
"     </li>",
"     <li>",
"      Risamine&trade; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10149285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691826",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat dry skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692076",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10149284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2733119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to menthol, zinc oxide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10149289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10149290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10149292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10149287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10149288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696549",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is used on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10149293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10149294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12245 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-403C6C9E42-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33267=[""].join("\n");
var outline_f32_31_33267=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15573799\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149285\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149284\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149289\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149290\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149292\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149287\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149288\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149293\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149294\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?43/43/44722?source=related_link\">",
"      Menthol and zinc oxide (topical): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_31_33268="Terazosin: Patient drug information";
var content_f32_31_33268=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Terazosin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36085?source=see_link\">",
"     see \"Terazosin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/14/43236?source=see_link\">",
"     see \"Terazosin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F225499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Terazosin&reg;;",
"     </li>",
"     <li>",
"      Dom-Terazosin;",
"     </li>",
"     <li>",
"      Hytrin&reg;;",
"     </li>",
"     <li>",
"      Nu-Terazosin;",
"     </li>",
"     <li>",
"      PHL-Terazosin;",
"     </li>",
"     <li>",
"      PMS-Terazosin;",
"     </li>",
"     <li>",
"      ratio-Terazosin;",
"     </li>",
"     <li>",
"      Teva-Terazosin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10013788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013790\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691233",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In men, it is used to treat the signs of an enlarged prostate.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013789\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to terazosin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013794\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are having cataract surgery, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698513",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If taking for an enlarged prostate, have a rectal exam (to check prostate gland) and blood work (PSA test). Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698248",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698997",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Erection that lasts more than 4 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013792\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695861",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695160",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are using this drug for blood pressure, follow the diet and workout plan your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10013793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10013798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11077 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-41275854C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33268=[""].join("\n");
var outline_f32_31_33268=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225499\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013788\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013790\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013789\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013794\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013795\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013797\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013792\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013793\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013798\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013799\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36085?source=related_link\">",
"      Terazosin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/14/43236?source=related_link\">",
"      Terazosin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_31_33269="Oxaliplatin: Patient drug information";
var content_f32_31_33269=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Oxaliplatin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/11/2233?source=see_link\">",
"     see \"Oxaliplatin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/49/33558?source=see_link\">",
"     see \"Oxaliplatin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F204261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Eloxatin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F6821523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Eloxatin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024757\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700363",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may happen. You will be closely watched by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700794",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause tissue damage if the drug leaks from the vein. Tell your nurse if you have any redness, burning, pain, swelling, or leaking of fluid where the drug is going into your body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702645",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to oxaliplatin, carboplatin, cisplatin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696644",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cold temperatures, cold foods or drinks, cold flooring, and the refrigerator or freezer for at least 5 days after drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697016",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy during care and for 6 months after care ends. Use birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698285",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness and tingling of the feet or hands caused by cold. Avoid cold temperatures, cold food or drinks, cold flooring, and the refrigerator or freezer for at least 5 days after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698372",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throat tightness, feeling of not being able to swallow or breathe. This goes away by itself. Avoid anything cold for at least 5 days after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697975",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698081",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698227",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the lungs may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698644",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698645",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble walking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble doing actions such as doing up buttons or zippers or opening tops of products.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change or loss of eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699003",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Seizures.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699035",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad mouth irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024761\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11021 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.181.191-AA596B28AF-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33269=[""].join("\n");
var outline_f32_31_33269=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204261\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6821523\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024757\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024759\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024758\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024763\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024764\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024766\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024761\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024768\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?2/11/2233?source=related_link\">",
"      Oxaliplatin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/49/33558?source=related_link\">",
"      Oxaliplatin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_31_33270="Adult cystic fibrosis PA";
var content_f32_31_33270=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chest radiograph of an adult patient with cystic fibrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 348px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows a typical bronchial pattern with marked hyperexpansion, upper lobe bronchiectases with mucoid impactions, retraction of both hilar regions cephalad due to scarring, and pulmonary arterial hypertension with dilatation of both central pulmonary arteries.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAXMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5WRGdgqKWY9ABk1N9juiMi2m/79mtHwggk8Q2qMMg7+2f4Gr0WLSYnOWj2/7tAHlQsLwni1uD/wBsz/hTxpl+elldH6RN/hXrqaRsHyYKj161cgWFQN0G4jrmgDxgaRqR6afeHnH+pbr+VP8A7D1b/oF33/gO/wDhXucUlssbhrNtpGCQ3H5VqRwWUqFYnaNs5UScc/WgD54/sTVc4/sy+/8AAd/8KU6FqwGTpd+B727/AOFfSR0vI6DnuvehLAINpAKn9KAPmj+ytR5/0C7/AO/Lf4UHS9QAybG7A/64t/hX0hc6Al0DJGAjd2xxVCXRVizGV57+poA+ezp16Bk2dyB/1yb/AApPsF3/AM+s/wD37Ney63pP2VwhXIblT6isv7GT1/AUAeX/ANn3v/Ppcf8Afpv8KUabfHpZXJ/7ZN/hXqK2pA5FWbe0JbOOKAPKU0bU3OE069Y+0DH+lWE8M68/3dE1RvpaSH+le46JYNnODn3ru7G2EEOCcsefp7UAfKw8KeIj00DVj/25yf4U/wD4RDxL/wBC7rH/AIBS/wDxNfWkK4OcZz2q6g3KCcLx0oA+Px4O8THp4d1n/wAAZf8A4mlHg3xOTx4c1r/wBl/+Jr7Ejz0HKj25qaJ8HnBoA+Nf+EM8Uf8AQt61/wCAEv8A8TUZ8J+Ih10DVx9bOT/4mvttVEiEAAjHFZU6gMRtAI/WgD47Hg/xMwyPDuskeosZf/iaevgvxSwyvhrWyPawl/8Aia+woZAhWPHDD5s1a09iwZQO+RQB8aHwV4qHXwzrf/gBL/8AE0w+DvEykA+HdZBPTNjLz/47X25IgZQqniqskOwgkL9KAPi3/hDvE+P+Rc1n/wAAZf8A4mkPhDxKBk+HtYA/68pf/ia+yLh+CD9Oec1kXt3FFnzCAfVj/SgD5MPhPxEOugauP+3OT/Co28M68v3tE1QfW0k/wr6dm8QWUbbS25fUdqhuNRtpNuWADdCD1oA+Y20LV0OH0u/U+ht3H9KjfSdRTG/T7tc+sLD+lfS1zaQXceEdQ/UCsa400q2yRAy+hHBFAHgH9mX/APz5XX/fpv8ACnJpGpOQE0+8YnoBCx/pXtz6Gd2+2BKk8x9T/wDXrqPD/h3aFeWM+aentQB85J4Z16THl6Jqbf7tpIf6VJ/wifiPn/iQavx/05yf/E19c2enJbAtgbyO3arDWgZlbbnaOKAPj/8A4RLxISAPD+r5/wCvKT/4mmy+FfEMQzLoOrIPVrOQf0r64uZfsa4AZnx1x0qg101yAt3Ekq54HTFAHyrB4W8QXDlLfQtVlcDJVLORjj14FSL4P8TMMr4d1kj2sZf/AImvqu1smhlM2nMA5XaUkQNwevXiuq1CWR5TdpqE5jknc+RHGqnZk4CtjgjjJPXtigD4pg8I+JLguIPD+sS7Dh9llI20++F4pZvCHiWCIyTeHtYjjBxueylAz9StfZ89lbxx6W91CkdsrN56xS/e3YIJGc54JNZOtCM+UuqXDXN7kmUo4ZMZXaWx1AXcNoweetAHx4dB1gZzpWoDHX/Rn/wpg0TVSMjTL4j/AK93/wAK+0Tt+12JjzIwD+UhmXKxlT9xhwi5/hbcfes3XLNmvWkaeWSZlG8SMrsuBgAuoCnjB4Ax0oA+PX0rUEzvsLtcesLD+lQSW08SlpIZUUd2QgV9Yy2TEMSeOua4b4p2+PBGpPk4Hl7R7eatAHgNFFFAHSfDuPzvGOnp6+Z/6Laval04AjaPrXjvwrXf490tcZ/1vH/bJ6+jI7FXILYDdCR3oA5xLHDYA6npVk6ZHIMMNrdjjmt42SAgsT9c1NHAgx8nPqTQBz0ejyE4IXy+mSOtWZNJMa7shh39q6a2hLkgqauxWAYZAwPSgDjbYTW7AQZxnBXqK3bOAXce4oqTDorcA1YNmkMjBYwSD1I4/wDr1BNFIxBZjkdPQUAWDbNFhFIwOvHWoLixWZcgfN6+lXbOQsm2Uc+verqwjqvbvQBxOq6WtxEIpR8wOQ2OlctLpjRSMsgww9uor1q5slmTGAGHesq+0pZl2uBvHRhQB5nJaYbhc+1aunaVkgzKQMdBXQf2K1tLmVMv1GemPWrlvY8EkZA5JoAZp1sNwCrhF56dK10VAeSM+9Z0l0kETGNwoH8WOvsDWW+qhA7qThc856mgDqN8YO1QS3t2p0U0ZYKXz656muDPiCRlKsxJJz/k0lpqMrvxIyEdCDQB6RDJET8sgz71aiwW5AOK4y0v5H/1h+Y98frW7YXhyMtkD17UAdNGAUwoAGKybsFJG6cdzVy3nV/uNx6VBeRiRhuJBzxmgDJuJgjli+09Kv6NJvY4/MnrSf2ZHLE7biSDkAVY0qBY5gMnHXFAGjGM/NyM+tRzhlZmLZJPp0H0q8UVQOBgnpWRqcz7mWIDGKAMHWL8W4ZYz8/Tce30ritXleQNvcjPU1v6vhXYE5bHJNc3qDK0R3naPrigDm7h9jleOnPOc1LbSRSIUYEFRlee3pVS6uIA2AS3PYdKqC8SKRT5ZJB596ANe3vHifAldMHoeQa6fS7lrh0hkCvuHy4Oea5SG2W5kXeHiUnO4jP6V2Gh2cUaEWjoWz8zvwQKAOk03RwriTGXJ4PpXQxWQRSVUbu+Kg0aYIio3I7v2rcRNwyD16Z5oAy1hLHJ6VFOc5WPOO9aF0hC/LnGecVRKYJz/wDroAy5IDzgkYJOTyOabsIGWwQPmAArSaLntz7VXkiw5HbvQBACee2egzV+zmbZtLZz2NVAgKgjB+lSxZUDqaALhtYbhiNvlufQZFUbjRlR8h1x14qXzGX7rYx6HFSQ3h4Rzx+hoAoLYJEuERcE56daFt88Dj9MVrbQy7o8jjoaIERsAgfhQBg3UYJ8sgY/rXB/GC32fD3VnHT90fp++SvTZrf524zXDfGqLZ8MdYyOgh/9HR0AfLFFFFAHY/CElfiJpJHUeb/6KevpqCE+WGyrf7oxXzP8HRu+I+kAjOfO/wDRL19T2Ee1yp6YoAbHCWHIytPjsIg2FZs/3cVbCnOB29KmO2FcnOP50AECRwrhucdhTxKvQdaqM5c5J47ClGSMGgB0mXbOcj0qvJEO469qse3GKcRk8kDvQBTSLY2QADnPSr1u42jd+NIsR6v19MYAqVVxjB5oAlEYYArjpxT1thIu4rz2NSRJ5qmNuBjGRwavbQFwOAP0oAx57JCMSgFR61yXiK4mijCWyMYj36fn6V2Gp3iAbAA3b/PrXGatFNK+8vuiP5D8KAOXvLgZVJZ1OOoXnFZeq3sUUARVdi3PJwMVtalZxv8APEvXn5elc1q9jOWjOOOmc0AUkvixIWMAdsGtCyuozywZSfTtVC3sgHHmOQDxhRmta3gjUARAYzzjmgDcsJXIBiKuB1Of0rorSbG1ZVKk8DPpWBZx4hyoBYnqOK07WZlJVju46Hk470AdPp+BJwcH/PNXb4sr7QNwPcGqFhho9y9Mc1cvG+bOPlx0oAfDJiJDjox71ctEAn3IOo71jRXBztKfKeRzWxprlicrjAoA05CAuPTpWTqH3G2nHJwa03ztGRyRnOKzL5SNx2nBORkUAcRrSybmyAAe5rg9aWbfh2LBugBr0nWISWZm4zx7VxOtqpQmMANjr3PNAHIvauQeM+1OitHAG6InBFaFrbzzN+4QsDx9K6DS9PEThpP3kg5A7LQAlhYSSiMyIyR4HJHJ+ldBaxlE8uJdqqMBcdT70xEkZy218Zx7flV6BjF13ZxzkUATWc7R9GIJ4Nb1hrMciiCUAr6j2rirrVI3LRoen3jjtT7OVWK+U2PY80AemxMsiBlIZD3/AMahmtjklFyuM89qxNKvJIyGDHn8q6WGRLiPMeQw5wKAKAhPTHfNV54MtkrWwY88jg+mMZFQTRAngZoAx9mACFLZPbtS7Nwznr6CrkkQC9MVEq89OMUAVnjz6Z6dKieI55z+FXmiJ+62OCBkZwe1DxewzQBXsGKOEclk9T2rRaAoxOODgj2ql5fPI/CtSzIlgKNyydD6igChJH8zHnB5rgPjguPhfrfBH+o/9Hx16W8ODkYDCvPfjrGF+FWuY4x5H/o+OgD5HooooA7f4LjPxL0YDP8Ay26f9cXr6rtRnnGMCvlT4LqH+JejqwyrecCPbyZK+srWMBQMdB0oAsRooO8n5VFU3JlfP8PUe1Xbk7Ylj6FvmYe1VgoPPpQAwJzTlQge3Ye9SDAZVyQzZwPUgZI/KpQvNAEJjwRjn3qVI+cj86cV59v51PDHz/Q0ACRAZ6YHPNSJFuPPTuasKmegH49qmCD6IOf/ANdAEIXy1+bgf54rPvdRChgx2jtipb653sypkBcDpj8R61zuoyKo+Z9xJzz2oAfKxmJIHXnNVTGA4yQefwrOnvWt3zIwRD0Hcj2FEGqxSY8kblz1c8j8KAH6jaLPzHmNhyeMggGsHVNOdIW80qADkEc1vTztNHy5I/SspPNSSbzWVkLfu154XAGDkdcgnv1oA5TYqkszx+yrn+dPjQMQqsP5VtXOnW8pO2FgWOSVqB9IEWGWQkgd15oAltDLGArAYxzg1tWabzkAegBrDhtJQcrKpA7EGtjTwyyAZGR6HNAHSWCGMoUJVTxitueIMc4XOM9KzbDnuTjv0rckXIXaAAVA/GgDPjhjZuIxnFalhCiZUDt0qO2hG4tgkDqa0IIgjH2FAD3UFVxge1Zd1HuYkjJ962wuBzyKoX+2O3aVRwB+RoA4PXoWaUruAQVyt3BaRgBmLMedp71v6vNJPLIBkg85PpWBcQSk5C5B4z3zQBQeUghIVEQ9B3q7ZRPIrFmOcUQ2Bd/3sqqF9OTV0tbwx7Vd/MYZ6c4oAhkcQwl3ZgE53g1l3GpyzBjFK6KOgB60y/ZZlffK+OgAXjNZM3lrGQs5zjuuKAJRqtwr4Lh+edwBrSstViZgHRo/9qPkfiDXLCJmbETqTmpovMiOCN3uDnFAHqWj3ZkTMcglHqDgj6iun067w4wwB9q8n0S4KpvV+p4IbvXZ6VqZIAnG7H8Q+9/9egD0eF1mj3KRn0oZN4OQc1i6deEFXRt6e3UV0KlZF3oRyOaAM6ZMrxggVVKBF6cj1rVlh2s7bnO85wx4XjoPQd/rmqUkZBYZ5IoApJIzJ8y7G7jOR+dSMuevJHfNPC4OMGhVAAB6epoAj2gMTn61LaEpOrZ9vwoKgfxZb3owcDjnPSgDQaNXXHGR2rzr4+QlfhLrxxgfuP8A0fHXorHKbhz/AFrz34+N/wAWi14HnHkc5/6eI6APjmiiigDufgiM/E/RR/12/wDRMlfW9qoUZOCe1fJPwRO34oaKf+u3/omSvraBicfXrQBHMd8zEjpxzQAc0KN0jHOcmpVX86AEVBuG4AnqD/WplXpTVwOxNS7QR74oAZGhLe3rVy3jI649qiiQ5wetXogPwFAD0XAx05yeKgvZBGu0dTzVossaBnPJ6D19awNQugpZpD16L3P/ANagCvdzcMdwVB3Ncvrt7sA+zjGT989RVnUrsuecnsB2/CsPUVeSAsQVA5560AYt3MWdiSS5OTzmobZ5EkMisV460tzKEG6NfmPHvVCS5ZTmVhGncMeaAOrsr6IoI5uWxkGr6yI2DGF254K1wa6rDG67d7+hzgVftdVcyfu0CY9KAOpumIjIwS1UQZDIpBJUjGc9KpxazJI5E+GUg5I4Iqa0voXcRuQsg/v8D8KANi2jDKuMD1q5aWolmCgd/SqyzKZcknJ/KtbTw27dgD3oA0bOJw3A+QdO5FbzJ90DAwMc+tZNipaRSN2Djt0rphGp5I7UAU7bKFlbAyOtX4Bvc9gB1pqwo5HAq9axhSdq4FAELZC49B1rG1HOJIyNquMj610sydQOD3rn9VQoWbr60AcDfWzK7bh8oPeqNyqCEvIRGq9Sa09WkjXdJI4CjsfSuN1fVopyURjhTwP8aAK093NdTNEgZUxjHdh70jTJHwGzjg85P41SMrp8wI3EHp/jVETgkqOHP8VAFnUJoEO1pHRiT2rAmuYlmG6ViOm0r1q3qCsVMzyREJww6H2rmp5/Ml3Ae2TQBrLcRPyJ0X0UnBFXrTeei7we681yruGJOfpmr9i8kW1kdlf2OMUAd1amJ4lDYGOp6HNbFiWDZjkJ46E81x9nqbblW4QTDjkcEfjXTabPCy5gcmT/AJ5scN/9egDqLC7aOcbXII9a7bQtQWQbScHuOxrzyzmV+GU++/qK6HTmaMhlJPt3oA7/AGgrg8elUZlK/KeMHrmpNPuRNCAfv49afIBKN6diR3GcUAZ7rhs9D3pMY4/LmrEg4Py8+9IqBiGoAg2HI9PTNIyjvU5ADKHwMnA560koHT0oAniJaIbutee/H0H/AIVFr3XgW/X/AK+I69Btxlcdf61wPx/z/wAKi1/j/n3/APSiOgD42ooooA7n4Jf8lP0X/tt/6Jkr63g4XkV8k/BH/kp+i/8Abb/0RJX1tF8qE4ycYyKAGRgH2z1qyF9elQxDBz/I1MDz6UAPCnB2gE9gTgVLtx/+qmoRuHY1Ix5/DtQA+BTnHGzrnvmr0a5HAAHSq0IzgDI96tM2yMtjGBQBV1O4EMWc8emeprir+V5JWK/MxOSTyK6LU5DLXOXQ3ZEeMdz6fWgChcSLFz95z39Kxb25hjINxIckfcHJP19Kn1HUBHmKAlnzzMf6Dt9a5W/lKMe79cGgCvqt48chEGyOJumOv4k1z8gkMrNkuf7xOc1qTbpRgjC9OazLmAwsCkhPoM0AQpPmPIHzdcH1rU0+4WRMbhuPTJrOjkRs74xkn0q/Zv8AZyjRqODngDmgDZjI83YiljwMim36MWOM47g9vf6Gte2nMtus0a7hkdKbbS7ZSJcSbicAjOKAF0a8aNAsr5HRQf4a6uzuZETKMWJ9axFS2KpiAZB4YHBxXR2ESSKvlkBscCgDpNGZnRRnD59OK6sHhcDqMEiuT0ZT5yqQQK6tMZUH8xQBLCmCPU9quwryOPrUNuvTODiriLg9cf1oAbIMZ6VzuvAmN8cnHSunccHIzWTqFoJSQV4IzyKAPF9ZjSSYpJk4OOtYN1pMW0yAM5/iUnAA/wA969O8SaGU3T2/DAfMuP5H1rjLiTykyF3NnBB/rQBzF5aPI3ysqIq4VBzj3zWJd2hjUSSSADB6Dp+tdhKYJ45XTMTgfMOxrjdddvmSNgBnkCgCjLbNcP5jS4jKYBY4rn2tykzh3DRj7oC4I/HPNblxxZwqTltx4B7VSaINJkspLDOM0AV7e1UgyOzY/hq0kRLARuc+460jPltqMvHHBFTW6jaG3KAD8xzQBatleEgldx9ewrSjnBwoOT7GqULvHMW+8D3XpWhAqScyIFY85HFAHR6RqTbhHODKox8x+8v49/xrr9OlztkjfzI84yO31rgbOEI37jLdiTxxXRaXcNC6lCdx4I7fjQB6Pp83KN0NdCCGjBXof0NcVp9xvxtABHYH+Vdbpc3nQlCfmAyKAEmUbs8nJxx2qAYVzntWg6HocZNUnXmgCI7UOVUbsYLHr9M9cUwnnj8afjnA/Co3HTHfvQBNb/UHiuE/aBK/8Ki10Ac4t/8A0ojruovvYPSuF/aB5+EevEdP3H/pRHQB8bUUUUAdz8Ef+SoaL9Zv/RL19aZIQjHOK+S/gj/yU/RcjPM3/ol6+sycJ9KAJIsHIHb2qVQcnOagiJHJOasxt6DBNAEobH4nBqVASwz19ai2g4zx68dangXJ7UAWYuAKZfOFUKSOmcZqeNct0461n30m522n260AZl2PlYbz1J+Y/dH4dq4/Wrv70cZwnf1b/wCtXQ390pBijPB+8fWuWvIQWYzAbsnv1/GgDnrwPIxwSB3Y1UcRiPrvfH3n4/Kr90WchFBJ/uKO1YV/LFbvukYu4/gU5x9TQBXunG0hmyeoxWe5JyW6eppLvUDKCAiIAeq9RWdMWcBtxbPWgC40kYIAdcdhU8N1Ggyylm/z2rHdXVucgYzSwNhh060Addpt6u9znYGB4Hf61v20AuAkqyqueOTzXFWU5WZSpK5BBHqKvLM0XypIY03ZABxQB2Em6E7CFUg8EHmt3RJTtBJ5rzuPWLlW2yBXx/F0NdX4c1ZZFzOpUjgY7UAer6M3mGM4HTmujt0Fc14XZXiDhtwI4NdXGRtBx+J70ATQxgMasKCeajiAAA6/jmphyefyoAHHHt61WmAx157VayMAAc1BJyOv60AYGox7kIwD+FeR+MJIbC9kRyMN8wxXrmryfI/JC9OK8D+ILifWZArZCrjA+tAGXJqZMm3BVHzjPPPauXuw+8g/NnnNXPm3HERJ6gHtT5rKRirqgKkE5z0oAzWX92ynICjtWY+AWPbFdHdQmFZEBRhjGeTzWTLYSALvkQMTnbjrQBmbRgk4HoO9CscDPQdBVia3YOQj7vU9BTGgCYaV93+yKALFndywMGjchu3cVv2N8shH2tcZ/jT/AANc4gO/iMgfmRV23l2t1IY9Ce1AHd2eDCWgAlQc7h2HuK2tMIZl8zjb0I6ivPtPuGjdTDJIr9mHHNdxpF0ksQS5KRXH94DAb2PpQB1NmXiZSDx/errdHu8tEVB64YelcjZsykLIMH0Irb09/LuEdW+XvQB2zqGy+T0qtKmH9R161PayBo0II6UTqQ/HQ0AZknDZ6CkKgYz0qxKnyk+npUJwwoAavXjGa4P4/kn4R69k/wDPA/X/AEiOu99s1wXx+/5JFruf+nfH/gRHQB8cUUUUAdz8Es/8LP0XHX99/wCiZK+r0J59PcV8n/BTj4m6L/22/wDRL19Wox2jIANAE6YyCcY6ZFWo+gH5VWj5PFWkXA7+tAEqkkgDoatwjHfntVaEfMMmrluu4njGBnntQBMSEj5POM4rA1CUqNijJPWty6fbCfTHSucvCAXY4LE/lQBk3X7vJBG4j8vpWFqbK0BeZlRB09T9BWvfOiLvcZx91fX/AOtXKajO8km+XDdhjsKAMXU795f3cY8lDyQp5b6mucvNpTamQ688963NRgyCyfLg5Hc1lXVjMcPIuMjjB/lQBhzEKcqcj6U1RIVDLnHXJrRnSKMZMYyeCD3qtKS6DA7cDHSgBhdZwscx2lRjI5qeGGIqE3AHPDY61R+YNyOfpR5m3ncAD1FAGxFCIpULjPPr0rRC27NyNqg8k84NZWmyRPE5Y7XTpjpVyKRxfOpXcrjAHX8aALz2OVDKAeST2FdJokKAKNhOcE471lQhksCrAlutdJ4btxPHHhsEdPrQB6R4ZT7PZr/DurrYeQCB161z1lEUWJOCVHODW/aglRkAUAXocAY9T1NTg4NQQjI5GCPWph90etADxyfSoZgQD6U9QQOc+/HWmyjsf50Ac14hPl2UrAjcRgE14JrKO95cSNuLjPIGc817v4rJ+zkA4rxTUQ0MtxCcEdQxHSgDk1IllIkO0AEnPFSM5jQKpYhMnIHYVBerErgpIZGc9BxUeoef5IIIIxg7c+lAEaTloJCFAVjgt3P0rMnkCE4cswzj1qO9dorFEjOATg1j72Zm5I7CgC27ux29CKbjnJY5HtzVMuyjAY+3vUizsMFsM30oA1IDsyzHr0APWrqBZHyygn1/pWPBNtOZACc9BWxp5jkYGSQxkcjI4/SgC7b2537ouV6BTW3p8gBCyghhzj1qnbgLwGBGf9ZjIrTgjQBfNdG75oA6XSdQKqI52yvRWPVa63TGI29CDyPeuAtomwDHhkBznOSPrXW6Dc5URMSFyACetAHoGlONqr6+/StGQFo+eo55/lWJp0hWRRnGCM5rcdgGxnOaAKrrkY9etVWXaxHWrsi4yAM1VlTLDpQBHjAHPB6V598fgR8I9eB/6d//AEojr0PaOffsOteefH85+Emu5GP9R/6PjoA+OaKKKAO4+Cn/ACU3Rv8Att/6Jkr6sj7cYr5S+Cxx8TNGP/Xb/wBEvX1ZG/zYGaALUXNW0PA659qqRgAknvjqeB9Ktx8EENn69qALUSjgsOhyMjvVqAEL06mq8Y46GrcQOcDg9aAIbp8ZyfwrnNQdUR3bgLW5dOHY45965bW5NzHbyoPIPrQBzepXJZyz5AP6VhyiVgSrDBPXsK2ZrffkyEgdl71QmSTIREYduRkke1AGcCY8hckngnHNZtzE6ghehOQSelaF88cBIMnmzDqqnhfrXP312875Y5UdAeBQBXnnhHErBnz1UVnlwXzGu0Hjceanl2zHLLtPqBVW8iMYG3LAjpQBDc2k6vgsCOzA8GqrwSYIwSRVtZpFj8vG4ZyBmpYXckMVVRnoelACaZZXMwPlqdijrjNanl+SIHyQxAySD71uaFJdRELEU8sLkAAZx71JPCt67uGwQPuE/rigCO3kndcI6t6gc5rvvCFsojgaVCrDn5q4C0gKgiIEn1BxXo/hkSi2j8xjyAAGoA7ewYs249e1dHa/w9T7YrlrFjgFDkeldLatlVHXjrQBprjA96fwBn371DF15BIx39am4YEH8hQADr2xUcxAB7cd6exI9MD9KgudwTv+VAHM+JmTyjuUe1eSa9btNMdqAgnnd0xXrusx+bgZGD+lcVq2n7y4jIU/T7xoA8uvNP2zllUYHIOOKq3VnMohZR1PIx613i2Um8JIAy54yvSnPpOZChj+VTgjtQB49q9ssTyhmZSD8qkfmc1iFVIxH0z+de3eIbWyns/skQgaRAQdyc/XpXll3pbxTMsJVlzjAB4oAxPIyBjG7rzTysajC/MehJ6Z9qum0MIx8rN/EQc1W8h25I+X0WgB9uEQBup9u1XEmwxOzO5cHPpVREI+ZkwB2qYAgAHJJ5FAGvptysGdnKkZIPT8q6KxuLW6bZEvly4/1bE4+oP9K5YQtCirMCHI3YA59q0tO2+ao2Fs9SxxQB2enNJAQu0EfSul0yMbvMVcEc4HrXKaVf8AmKqXGAvQOOCvsfaut0sNAqg9xkHqCKAOo0yXfjBIK9feuqiYvbqc4rjrT5WDpn3FdXYPui+negBzg9/zqvIvY45q5IMc44PSq8g9QPb1oAqE7e+K88+P5P8AwqbXc4/5YD/yYjr0NyVOOP8AGvO/j9/ySbXsf9MP/SiOgD47ooooA7b4Mf8AJStH/wC23/ol6+qoMbhnGcYzXyn8Gzj4kaP/ANtv/RL19U25wc9aANGM89OPX0q5BxgYxVGMkkAmtGAAYDA8+1AFqPGQAOAKsqdqEnjAPU1XiU59ulWJceUxB9KAMe/cqrdieAfSufmQqv7xixx1/rW1d/MxLZIHAHr71h6is0kUqwOqTYO1mG5FPbI70AZNypLEBQTnIPT8a57VLoYeO3ZyxHL+v0rZvbh5IFindc4wzrkAn19h7VzuoKoUlSAgH3h3oAwJl2H5mP8AM1TuHQYwfmB44zzV+VGdwEUgnPPXNVXs3bLECNfQ8k0AUWdpMqBtPrnFMa3kCDYCQc5Y9KvLboq4OM55yMn8qXcPlK5JXt70AZbWh9SDnqKmjskR/myQeR2wa0rVj5nzp8p5J9DWhFGs0m+VFEQ7k9aAH6LELVIzkANyynv9TWzFMJ5RiNFQc8LWJdyQbgkUqnb1X/69bfh795buj7SAQyMOcA9jQBq6ZaRM+/CqxPIA611mm27L95eh7Vz+mweY6+Uw2g8ketdrpEO6Ib8Zz3oAvWURD5I69RXQWkeMe1ULe3fCbNp5wc+ntWzAgA/woAlXO0AYzU2cA5pkfRc5qVRwSBxQAxhkdx/SorpSYjwM1Pgc0ki7lIoA5TUd3nDoQe2KyruyEq71HzD2rptRiAIKjHpWS4KklsrjqfWgDkruP/SEGzJJ5I4qy6xKAWT3b3FRazexwy5TGScZPbFVJLvzIwSFHNAHNeK4WDCWCMrI4PA7/hXJRW1zJGPtMZjkXIIxjI967TV4ZbuZJUBKqfvk4Uf59K5zVdRea58qCRSFJVpCPvkcflmgDm7nTU83cCoBPK5ziqc1uI3I+9j24q/d3lwlywmWNlXjGMiqctwowsq7foeTQAwDc4VIwcn+7k1IlqivnIjl9+g/Cn2uppGxWFgDj+7zTo5Y5nDsmcnj5v60AVnt50kLySeYufvZzVu1Dl8DBPfuAKuxzICFWGPaB7nFWliinclUEWepTjPtQBd0yIkq7YCg8DPJ/wDrV2Gk3WT5cmNh6YP3a5CK3EY+Q5UnqecVrWJ8vb8xJ9e1AHeWTlHUdq6rSOI+uVI4GelcRpU4lUAZ3KK7DSW5GSRnrQBsSYKfSq7jIGP0qdlzuzjPTPWqzEorZ5x6DNAFOcBSc9M5rzX4+Pn4U66Ov+oP/keOvTLtiVZexryz47n/AItbrg/64f8Ao+OgD5HooooA7L4QHHxF0g5xzLz/ANsnr6ot3BUeg6g18q/CRtvxC0kj1l/9FPX1DavgDGKANq2OT1HpWrAPQ9fasm07VqwtkcYoAuwYwWGDS3BHkNg89c0lvjH170t4G8lSABjJ569uKAMK6GTWBqc7fMoVSPWty7dYoztGMcAAdK5e8YENIVJx1oAybjO7kEZ6Lmsy5j8xmd23Adug+lbFyvmjLn5McjoTWTdM7SfIPlXhVX9KAMuddr7lPbqBWdM2SN/T2NaF7IsWS3bjaDWJfXDSZyQgHYdaAElZVbdkBh1APNQmcBJNgSMjncTkk+lUmb5WznPr/Sq/mHdnGeeaALwnmwZCzMh4z0Gas2Fz8xjcZWTg9yDWbJdySRbBxGvSMDpT7Jym5kJIx1PUUAaEkIDlWzkH6g10/hASfMqk47etYOhSvcyNHcp5iAckjqa9M8O2cEdis8aZ3ccjp2oAu2FqjM8qsqHjccdDXW6MX8kBvmGT0rAgSO3SRlIAxzWvoby+VgHPoG/xoA6uzYEhfQetake0g4wcHB+tZdgJMDeqhfUH9a04N5HzIB75zQBOo9BzTpPMELGBEeTIwHYge5P0pEJ47nsamXvQA04yQMYzxSEfIeKcSegJpG4HQ4+tAGbfIGHTk9xWFqKMiMR87fyrorpSSeOSePpWVdQkpkZyOtAHBa9bMtm8rRkcZU9g3vXMabJcXEZEqS4yOdpORXourWjvC6oM7uqnkGuYt92lu6xgqzcYYZAHpQBT1B4rWxKzuh3dAcde1ee/aITO5AVsE52jr612uvvHdAq+FGPvAc15xqVm1tfu3GCMlh0+tADbvzZlby0AY5we9YE0UqErcZ3ds1qx3kqlo1c89/Ws+acicI6kKT1I60AUWkKkqgx6kU+3dlfKkCpZkg83puB6EH+dKIzGwLKCDngD+dAGtp98wUiRdyH7x7/nXRWsYlZTbyAr1Cgc/SuQidz8oJA9PSr1tcfZpAUfc69weBQB2lp8shDKNmcEEZFX4oiMmJSFU8g9fw9axLDWVuSou1RD/wA9VGB+NdDaDa/RueeDxQBq6QxV1JyO+TXcafIfLDKCfYVxUKoXDRj94BkjFdTo83Kx57DigDrW/wBWrDHI71Wl5Jwc5/wqeP8A1QyG4/Ko5BjFAFGdQc569K8u+PYx8L9d69IP/R8derS4wcmvLv2gFH/CrNbI/wCmH/o+OgD4/ooooA6v4WEDx5peemZP/RT19O2rD5PWvmD4Ynb450s+hk/9FtX01YuWCEdKAOls+i8VqwKMZI596ybMnaM56VrW+SBxyaANGAHKqTzin3eCuOOODjnH1pIVw446Cn3f3CeDgZoA5TVW+YrnAHFc88WwAFiyjjLHJ61016q4LZ+b2rDlGWPA4BOT296AMSaPMjbMknJYngY9TWFqmojLJbMABwWArR1y6Z0aOMZhPfP3v/rVxV7IcnBwQw6dKAIrmTIJOWJ71lTBh6Yz61akuCi4bac8jA61CIWuE+Rck9PpQBDiQxN1J7VAY5GXAXIPHPArUttOLZ86URj0HJPtTktYemXOP73AoAzI4GVwFBLd62LGwLh1lRlI5yDjNWYljEfICntnrU4ZyqKgGCeDjmgDU0SyjRFdlCE8ggEiu+hgktLeNAGwRkH198YrC0C0ZbVFZXcgZYdq6C5kmZrdQoVVXnf3+lAFW7ul2rEVySfmJziuv8Ko8kZMiYOOlc9Bpy3EolwTjGB/Wuz8OxeWpUnPOOe1AG3bqcdOnar0YOB2/CoYkI/wqwq5xzk0ASKMZ/wqVTxTFHINSDnpkelACYPPHBpSDj5vT8KXGQfSlHTJzn0oApzjGB+NVjDnORwavSgHleAahC45OBQBl3FrySoGK5bX9N3fvFGGHOa7eRcFuv5daydRjR1PB3H9aAPHtQhJYxs2STyCw4NYWuWKNZnaUHZuxNdt4zsFtoGvFjm3KcnAAIFYOmix1DSZd7MZguDuHJH1oA8+XTIZJ9nnbe+Se9M1HSCkgEk6s7n5AeMjtW9d6WVut1v84XOSfSs0zbVMM0eY8kdct+dAGALF7cM8sahfrmonkJBxIOe2OlacrvG3ls27+6o7Cq91bAxBgoJbr6/WgCCJ0aPAkBbHOBU0KCPrjgdM9aoMvlZZfnx6danhuN/3Rtz04zmgDVtJAWDEAD+VdfoV75aKkpLxY4PQoa421kVpQcgHuBxXR6buABwvB6qOaAPQbIkEFnGwc7sjBFbtr8squv44rl9DuSIxHLgIeh/u109ouJVBBAoA7S2bdAjAnHWiXOcN1/SodM+a0IIBAP6VPKMp+PIzQBTlFeXftAf8kr13PrBj/v8Ax16nNyMdPwryz9oHP/Cq9cyO8HP/AG3joA+PqKKKAOn+Gv8AyO2m/WT/ANFtX0npLksi559K+bPhp/yO2m/9tP8A0W1fR+nHE0ZB70AdlY52LxWzbjgc/mKxtPOVHHPr0rbthkUAaMK9AM0zUCPIIPQ9alhHA646nmoNWbYFHqOfWgDnLhX8zgcmuf1t1MbJE3A6jP3j/hXQ37iJCc/Me57CuH1WfY7Z24x2PFAGBqbMpYlwvXjrXP3UsMjAmMtkZ+U4rdvoTPuKZyVyR61nLbxxfdA8wfw9t3rQBkrbxMN7B44x/e5P5Ug8tU/d7mX16VbkI3t5xTYeu0VRlMat+6Y7T1OOKAHFwWDH5MHnuKnimSaQKHAbu7DArMndNoXeB6kHrUSReYcmXKj88UAbPnWqtl5d46ExDr+NdLp0sSRK6IIoh/ERuP8A+uuJt4YwigF1JOOB1rqvtMTLBboWXGAFHc/TtQB0NnfvJchYGbYOcd2+tbuC1uJA7OR/tdBXLaTG0U8oU5AXHynAJ9K3JbkxW8cYIJC5JoAvQ6i8BEZcuF5AB/Su48OXcssYd8cDp0rzeO6Fw0NrDCic7mY/e/PtXofh9xGEAXgevWgDsoTuQGrKc9RVW1YMgJGKtR8Hk5yaAJQOeOfenj8DikHXOPenD1OKADPbv/KlAx70c8dz6Uv160AQSD5RUG3HNWpR0OMfSoG6n060AQN94Z/TmqNzbhxgjA9K0COcgEc1Ex2EjHPrQBz+oWKXELxSxhkYd6801LRX0ia4aFMQucbs8AHtivYblmyFCIc9icVg6vbi5gnhKqydOR1oA8O1AGIkxHL45xx+lYV8QjCT5cjqR6+ldJ4mtbnRbxzJCJbRidki8bT6GuNu5Ek+dGyHHIB6GgBt1dQSRAEDzAenc1XSUPGWVeB1XBJFVvMXcFkiJwf73SlKFgwgc/NwQev0oAmcMHDbFIPI96XykmfcdsR9VPT8KhtpSXaC4cYJ69atx26JJhW8wjv0zQA8xtAMqC3o/Y1uaTKVCmRQQR1PBzVS0QSsyhWAPVSeGA/rWlFYlSXjDYGOO9AHRafdbyNwBPTpXZ6TcedEOcsOh9q8/tJtjLj5D3x3rpdCuyJxgnjrx1/GgD1DQ3LQuD0HTmr7AbGBxxWRoTgE474ArXfg4OR3xQBTmHy4647V5V+0F/ySvXOnWD/0fHXqs2cE9a8q/aDx/wAKs1zkdYP/AEfHQB8e0UUUAdP8NOPG2m/WT/0W1fR1hkOvNfOPw0/5HbTfrJ/6Lavo+xXGznOPSgDrdPPyAnJzgcDP410VoOK52wPCnp7CugtDgcnmgDVhGQv061V1fnaxPAHWrduePWsvxA5S0ZhjduzkntQByOr3e+Qjdx+lc7eK0pIJG3rkVqXK+czbjgZ5NZsuIxiRv3YOOKAMGYlY8R5BJJ561nzxtMrDhW9uv/162NRRF3SB9ynoucE1zd3dNA7SJLiReAq9B/jQBnTgJG8kjqi54BHJrNnu2ddiSbV7gDGakvZZLlvnHsDj86qCEhgXzg8YoASOISuBvySeauxWhVC0mAnQY5pIBGqGTYdoyMZxSNO0hxjCDoM0ALukZtsO70rotAdbT99JmSYnByO9YqTtGoK8A9gK2tEtHnuVeT5U7lhwKAN+0uWnvMRDagXJGMc1swxbztZRhh1qjYQ28CkxYdS2N3pWs8bm5hCsSijOPagC1pGmKL9pcjYfau70qDBBydvpisDREZo0WMfLnOK7PT4Nh5PP8qANS1UCPnrV1V6DjnkVWgXCjAH4DFXEzwOmaAHKDnnPXsaeM/TFJz+PrTh6UAAo9KMfSlA9qAI5eozjGRioCPTPHU1Zf7tRFTyOc/XrQBAy446ZqGSPngdatlTkcYHvTCuDnqMUAUZYw2ARgiqEiEucqvz9q1ghKYc5OOo4z+FVngBY9sUAef8AivR4bmKRmjDQupDrjOD64r571rTLjRr10fLKSSknZh6V9Y3lpuLjg4BGD3zXmPjbw0t5azROu3+JSR37YoA8M3pOpVwPNXjOaghkaGfa5/8Ar1PfWUlldyQyod6k9ehFVirZEe7PHDZ4oAfOr28+5BkZyrAdvSr9k5aQN90AgtuqKzuJQVikVWVeu4dPcVLht3yuQrHmgDagOWDR52k54PWuh0qYR4LgsewzXF6dctDNsfcFPGK6KxmRxtV8ODwCelAG+6qVzAg3HmtPTZcIgIbjpng1kWG9XwwIJPBI5+tasMLGTegH+1jvQB6R4bnDWa72AO7HNdLMcAE4/OuN8NSBI0jIyrDBB9K68cqoA7YoAqzdD15/SvK/2gefhXrZHT9x/wCj469SnO1m9TXlv7QJ/wCLV63zn/Uf+j46APj2iiigDp/hp/yO2m/WT/0W1fSViOE5xXzb8NTjxtpp95P/AEW1fSFgWON2AvG3B5989qAOsshhQa3rdsJ1J79KwbLO0YBz7VuWnOAQOT+BoA2ISfMT7uzHPXOf8Kx9ZfeXUMMDitYsEjZueBgcdKxLw7twHJoA5W/AhkVE285IB6n1wPasa+kVVDSnc5/hFdFqYijj3yqpkAIQ4GR689QK4fUJ23ySSbsqMAds0AZeo3zJKVypGOcc5rDmCEM5UKueCO9Xr4ltzN8oA59axLnzJCGAwPSgB7urqFjQbyc7vQVFGEXJdOSeveliVIk3sCW7DPFRgtKy8nB74/lQBMQjIpUfKGxipo7VGTcY2RScAnmn2cO6QhF3KM9a3YLULbxvKdpLY45oAz7KxXzV2k7P4ie1bLFIT5YLZY4K+tBhReC6rH6kdfwqWC6t4kEyRlpz92RyOB6igC7b27Iu1m2qCPbHtXTR7DhlYtgD2BGP51yBkefflmDOclj3Fb1gx+xg7iTjAoA7HSrkCVI44x5aj6YrrbKUOFyAR15PSuH0eV0jRXwTjuOa7DS8MV2g8HvQB0MZyBn9KtJzyQTj061Uh6Z61bi4oAmHJzSgU3B6Dg/TNOHB9hQAv4Ud6MUtACHGPrxUbHk+tSHAHJ/WotwYnaCffPFACHjAFMY/Lgj6088k8Zx6Ux+OMAY7UARjAPyjBqFkBPGKm4BJznNRSDDAgYOe1AFK6izjrmsfULYyxuo79Qe9bs2QM5JzWddfeBHagDxTx74TW58+W3/dzLyo7N7V5isLBAvkBWU9Vr6X121SaMuQMj0rxvxZpptLsyx5AmJDegP/ANegDkZIPOhIRP369WHeqVszRExtzg556g1ovEdxeJsOB93PBqncQh5iSmDjODxigCSWQxnc/wAyN0OKu2xA2ypls84BrPhnjKASxludpG7FXIGWKIsgI+YEHrigDsNMuQ6qJNyseOTnFdLpimR1z06DtxXBafNuceW2w/xD1ru9JuP3CgcEj5SR2HagDrNOyjLtOFHT2rsraUSwIwIPHNcRYSAQAk/e+7XU6NIfKeI87ADxQBPdnDMOQDzXlfx/P/Fq9cBPP7j/ANHx16jeH5cn3HNeU/Hw/wDFrtbHB/1H/o+OgD5EooooA6X4cnb40049OX/9FtX0lpz/ACKfwr5o8Ats8W6ex7F//QGr6L0qZvLywXbxg9/xoA7XTjkAgfSt6yxvU+grmtKdXQFSCD3rpdPwSe3Hc0AaEsm21we9Yd3IoO9mOzbk5rVunBjCr78VyuuXJ8sKOVU4/H1oAytXuC8pYYweB3ArkNWIkkBU7SOntW1eXiujKWy4GOKwp3Vz9zOOQD2/GgDBuwxBQj5gck561RdBu5BVPcV0dxBHKmQRnoQOufb2qrNEIYiZVAkJyny9qAMaa1aQggEIvCgjr70+K3IbghiavSRu8W05AHzEnjFQyyhFUptOF7cYoAtF4bSJUXPmZwT1FWjeiGBVDJvXk57CsG03TTrucHJzuJ4FSX8u27IjKkg59etAFu4vXnbc5Ij9OhY1JDMrcMxLYwF7Zqgoluh8uflGCAO1XLOH5iZEdgD2GM0Ab1i7NAQ2DsGV/wAK29PZ1jQu5CYyQBWJYxlpFjgiIDkcH+Gt6dHjuo4IjuSPG70+n+fWgDrtNRZgssXyocY9RXW6amEB5JPrWD4cgHkqCvB5we1dPawkHB4xQBqQZKjJq+gwF449qpwIEwB6dKtxrhmPPzds0ASL7Y+lOHYUncd6UdRQAvWl9aTNKKABv8mozUhyBTMHINADM9c9qY44PHtUoH5Z5pH9cCgCA9CRnOKibGQSMGp2wBzj3qLA9SfegCvKDtP8qzbkAhiykDHTPNakobBxjNU54ywLAc0AYF2waJlABGOjV5v4qtlkSSOVTh/ukjpXpd9HkNgHIrjtWhW6do5MZP8AF/WgDxW5BtZ5EZc84PHXFWI4ElQBlG3qAD8wNT+JIJLS+Vjkrkq3HX3qhBMcBkZtwPAI/WgCLULCRULwp5gDcHHf3pmjq0Q+z3BMhd9zsegJ7D2HtW/bTG6gAcbSvBI4p4063WISiTy25O0jJb6UANtrf7K4G7LDoa2LK4ZLhWRiVJ6nIrCMu1lDcpnAPcVbhnRXVN+ex55FAHo9heLcqpB6cEe9dTpFz/pZB/jXFeYaNfmK4XngDkeo/wAa7TQ7o/bl9+5/nQB1d0f3cm3C856d68o+PT5+GWsjt+5/9HpXqkx3Bh6juK8m+O7Y+GusKc5Jh/8AR0dAHyhRRRQBu+CTjxPYn3f/ANAavoPSmDRL0/OvnfwiceIrQ+m7/wBANe+6M+Yo8cCgD0DTXyikkfhXT2BCwO3t3rktKY4QCumEgS2VFGTnB9qAC/nCQEE/fXGM9q46/l3xtGhHIwPb2rR8QagqzLhiQo2jP65rj9Ru2MrAEkeo45oAp3Uo3EbskdcHFU5JSVK5UORhcf4VFdMFJlODngE/570+1hkuG2QRPNck9V5x7UAPRMFeQHGC3oPX8fepZWDKC4w3QEnqP6V0Wk+FriX5tRkESDHyrz+ZrpbPw7Z28h8uBd2MFm5JoA8qOnahekLaW08qnqdu0fiTVu18FahI2yZkiy2TtyxJr2azsFTI2Dn25GPQ1bt9OQAnaMj17UAeYaX4ItYOZg8kinvwD+VasPg+zjcv5A3t1JFd+ttHH8pG4nv2FKLUGUxFSMY2v6+1AHFReHIU+7Gox0OKvf2BCefLXfjpjr712P2EY4XnI+UdqfHahQGlKovAyT+lAHJWfh1Y13hFyegI+7T10RT8569OetdmlvuztJwenFItnk9OvegChp8CxKgUY7c1vQqCAT07VQMSQnLttXOBn1rQhwFwORQBaRRwKtp09/5VVQ5x296sIM4IPH86AHjkdc04deOlIODjrQM57Y9qAHdvalPXn+dIKUdMCgBD+tNPuadimtwKAGkgn/61L3OfyqJjnn8qTdjIoAVxkjk4HYd6iYc/060pYYwajYgg0ARyHnpx37Yqo7ZOQePWrMp3DgZPvWfdNtYgjJPpQBSvkBDYOAw6k1xOpQssrvkcdRng12l2FkRlP159a5jU4C0m73zzQB594qsDLbyBF+ZhkHHQiuEtbd0nKyoxYcE+let3cYljKSHnqpHavPdfhW21B8EYbkKDjmgCqkyxSNnkggfL0Iq8pHmAqS2R0z0rBmuFUMVCkZOcnkcVDHqAA/dtls9Qe9AG5f5ADR4808FcYB+vv71QjuEQ8Aoyj7pPSlt78FPLm5yMgZ6GqN2okYNC2T39/wD69AG9b6gREGLAE9RjtXZ+DtS82UKSN0Y4yc5FeWR3QXGGG31963/Dupm1uVcEZzg+470Ae+wy+amSevBryf46n/i3usj0MX/o5K9F0i4ErBVztddw5rzf47N/xQOsDH8UX/o5KAPlqiiigDX8KHHiC0Pu3/oJr3XRn+ROegrwfwyca5an3b/0E17bojKUTIyMcj1oA9L0JtxQ9cDNbuoT+XaFtwyBgc+tc94dJ8kspUD7p4OfwqbxLd+XGIsnjnI7UAc/4hvAWReo2muUvLoEgKwL55I9ava7c7kV0J5O0Y+8a0vCmgGMrd3aBpP4UPIX/wCvQAuh+H5dQVZLsbExwnfH9K7rTNKhs0EcUSxx9MKOvvViziEacKWAGSF6n6VrW8KvhkI2thsgfeFACRw7UVTx9aswwhR82SexApkU0LXptfmaReuOinrWokPI4oAbBGBnOMn17VYVMZHYdzT4o8Hlh6fjVmJAePyyaAKjWkZDr5XMgOc9CenNSwRp1K4bGBx2qwgSSJipV1IIORwQMg5/WpbUpJFHJH8yOoKnBGR2680ANWLOM/lT2jU8EA/UfrUuML93npgUpXk7sEDoPSgCILuI4G31z1poXPUEHnvVgjPJ6dKXbzQBVaHcOQD655zUkaZ68ip9nFAQjHHGOaABBtzjg+9WF4AGc47k81Go5+lSjrkUALnBxinD86QUv4HNAC+9Ln0pPxwOvNKOmRigBDj86idc9alzikJ56UAVz19c9MUwqxAwD68VZbBGCOvb1pCTj2NAFZoyBycAfjQsSnqxIqxyOoGaZzjLEAevtQBEbaNjk89+tMe0hb7yZ/GrCg5LHAz0HpRgAHofrQBnPptocfuunuarTaRYOTm2U/Uk/wBa2GXnkEn+dNZMgkcUAYB0exQgrZw5B4ytZuraHp8mWaxgZhyD5Y4NdW6k9eT0qGeJSmMDNAHll14c0uaRt9lEN3/TMAVi3XgrRZCxFqiv6qSK9LubIB328Cs24smOXA+tAHj2p/D7JL2NxIMnoecVhaj4d1LTYy0kXmJjlk7Ad8da9xNowbdjA9D0qO4hWVCsqg574oA+bbnCkvGMr/Fjp9al02dpLmJg2cEAe1eo+LPBkF2jzWiCK5I4YDr9a8wi0+fTNUW3uIyjA8elAHtnhK+MnlDOTG2PwNc18e+PBGrDJ5MR/wDIqUeC7sx6xHC5xvBXH8qT47nzPh5qEn+3Gv8A5FSgD5cooooA0vDxxrNsfc/+gmvZdCl/dqQcivF9DONUgPuf5GvXdBfdHgjnGeaAPVtAYiCFORuXf+Oaw/FF+G1O9UE4RgOvQDitjRQubcgkbQPx46V5zqN9JLrVwFIZppGULnuTxQB0vhnTjqlyZ5FBjiPyA9zXodnaxhAqKuxRgewHasnwtZfZbGKIKTtGWIxyf0rqrdEjxtXGT2U0AS2kJUAdMetaEafK+GK8HBAzioIgu/GV9cE81dh4PGce9AEOm232dJ2lBYs+8MwG7PfnvyTWtEoz71V2q/lhyCynII4Gf89qvoFwCCDxjg54oAWEKxAxh8dMfyqXy8PuH3T8p4oQqGVc8nkD1qdAv3Tn+dAD1XPOMe1PA5OaRRz708DAxigBAMdOQKXbgnjqaXHp/OnYwenFACBcgdPrQAOemfSnLg5AzQB3PGP0oAFBzRjp/Klxz2x2zSj1/H6UAJt9+fapBz6VHGiooRFwo6DtUgGeTn6mgBR1PIwPSl+gpBx1I/Cl+hoAOMY6+oNKPfFICO3b0paAF7YpmOT2+lO5/wAikzknnpQAgGP/AK9IMsoLKVPoSDj8RSsQAR1+vemFjjPWgByqAXwWOTnBPA+lIyDOdufTnpSKxLELjH1qQcev0oAYVwO2aY/HU9KlI45OaYRlfegBhyPp9KafvH1p3PakyoYLuUNg4GaAIXDNIoAdVHzF1YYJ5G0jqRzn8uaZKBtPGRjGasHI64qJ/mTjOOnSgDKkiA4A+UDAqq0JYnIP41qyLtBLAn6daikXj0IFAGLPCrjBGPYcYrKmgMb7hnA710UqjeRzn6VRnjyCDyKAMN4g/Xn271yPi7wzHqVq8kSgXEeWRh612s0flNlRgd+KYYw6EHOOmaAPBdGvWtNWjlmJVo2AbPYg966X4zsH+G2r8E/6hwT/ANdU/wAay/iVpTaXqv2qNQIrg4OP71Xfi4/mfCy7kAPz29sTn/rpHQB8z0UUUAXNIONRh+p/ka9V8PSfKvJ9DXk1jIsN1G7nCr1P4V2+k+ItOt1Aludvf7jH+lAHvGmyhIgx4AQY/KvPdCtWvPE4YDcY3LDHr2/rVq1+InhtLRFfUiH2gEeRL/8AE1B4V8beFNPmnnutUCySMcf6PKePXhaAPbNLj2RIBj1JxWxGOcj6c15fa/FnwXGBu1oA/wDXrP8A/EVfi+MPgdf+Y7j/ALdJ/wD4igD0tFIX5Aue2RxVmCNCdyqATxnvivM0+MngQYZtfIPTi0n/AD/1dTp8Z/AKgD+3hjPIFncD/wBp0AeoRYwAzOe5BORVpA20dz2BHH515cnxr+HoIJ1/n1Flcf8AxurEfxw+HYPPiE4HpZXH/wAboA9Py3JVY8++akRiTggE9evSvMF+Ofw7CADxDnAxzY3H/wAbqQfHT4c4wfEXB6j7Dc//ABugD1JW4p4IOK8tX46/Dgf8zFj/ALcrn/43Sr8d/hz1/wCEj69f9Buf/jdAHqgxjHWlAB5wK8sHx4+HGP8AkYvzsbn/AON07/hfPw3/AOhjP/gDc/8AxugD1E+oJ47Cg9MivLv+F8/Dft4jx/243P8A8bpsXx6+HDJufxAY25BX7Fcn15/1f+c/hQB6ljPelwQDzzXl/wDwvr4b5/5GPp/043P/AMbpf+F8/DYAf8VH/wCSNz/8boA9QViMbsA/Wn5zzjmvLB8evhtnP/CRken+g3P/AMbp3/C+/htj/kYx/wCANz/8boA9Txn396d0PSvLB8fPhtnnxJ/5I3P/AMbpR8fPhr/0Mn/kjc//ABugD1LnHH60jAl0bceM5AJwfqO9eX/8L9+Gv/Qyf+SFz/8AG6P+F+/DXP8AyMn/AJIXP/xugD1Ln1xQ3XmvLf8Ahfvw1wf+Kk/8kbn/AON0x/j58N8HHiQ5P/Tjc/8AxugD1I845oIH4+prytfj38N8c+JP/JG5/wDjdOHx8+G3/Qyf+SNz/wDG6APTwMHNSfQYNeXf8L8+GvGfEmfX/Qbn/wCN0D4+fDUf8zJ/5I3P/wAboA9RA444NNIODgYavMD8fPhr/wBDJx/143P/AMbpv/C/PhtjnxHz3xY3P/xugD02RRICjYxxkA/lSnDHI/OvLJfjv8NSHK+IVDkdRYXIJOOMny+aVfj18OMAt4jG7HJFjc9f+/dAHqPrUbjBztya8x/4Xz8N/wDoYiP+3G5/+N0n/C+fhx1/4SM5H/Tjc/8AxugD0pxznoarSryB09PevO5Pjv8ADg9PEWff7Dc//G6rT/HL4duQB4hHHf7Dccf+Q6APQpMMDg5qpIvBBHNcE/xu+HjD/kP8/wDXlcf/ABuqh+NXgPB/4qLfx3srjP57P6UAdxcxgsRVKTKk5OSK4uT4z+BWB/4nuD/16XHP/jlULn4veCXI2a4SB/06TjP/AI5QBueNtLi1jRpInI3qNyt6GuD+LCtF8KJ0Y5ZYLdD9RKlar/FfwVIrK+sZUjBBtZjn/wAcriPif468Oa14PvtP0rUvPuJBGETyJFziRWPLKB0BoA8MooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33270=[""].join("\n");
var outline_f32_31_33270=null;
var title_f32_31_33271="Scimitar syndrome";
var content_f32_31_33271=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance angiogram of scimitar syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 615px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) View from the front of the patient.",
"    <br>",
"     (B) View from the back of the patient.",
"     <br>",
"      (C) Reconstruction of the scimitar vein and its relationship to the pulmonary arteries.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Courtesy of Brian Soriano, MD.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33271=[""].join("\n");
var outline_f32_31_33271=null;
var title_f32_31_33272="Prenatal US ureterocele bil";
var content_f32_31_33272=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81543&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81543&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound with ureteroceles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 541px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prenatal ultrasound at 22 weeks gestation that demonstrates biliateral ureteroceles resulting in significant bilateral hydronephrosis. Panels A and B demonstrate left hydronephrosis, and panels C and D right hydronephrosis. Panels E, F, and G: Sonogram of the bladder with bilateral ureteroceles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Laurence Baskin.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33272=[""].join("\n");
var outline_f32_31_33272=null;
var title_f32_31_33273="Risks and benefits of fish consumption and fish oil supplements during pregnancy";
var content_f32_31_33273=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Risks and benefits of fish consumption and fish oil supplements during pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/31/33273/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/31/33273/contributors\">",
"     Emily Oken, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/31/33273/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/31/33273/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/31/33273/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/31/33273/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/31/33273/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fish, including finfish and other seafood, is a healthful food that is low in saturated fat, high in protein, and contains many beneficial nutrients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/1\">",
"     1",
"    </a>",
"    ]. Most notably, fish is the primary dietary source for two n-3 (also known as omega-3) long chain polyunsaturated fatty acids (n-3 LCPUFAs): docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/1\">",
"     1",
"    </a>",
"    ]. For most health effects, the relative biologic importance of DHA versus EPA is not well-established; however, DHA appears to be more important for early brain development.",
"   </p>",
"   <p>",
"    The n-3 LCPUFAs are essential nutrients that must be ingested and absorbed from the gastrointestinal tract; they cannot be synthesized de novo in humans. The parent n-3 fatty acid is alpha-linolenic acid (ALA), which is present in plant foods and nut and seed oils, particularly walnut and flaxseed. Enzymes in the human liver elongate and desaturate ALA to produce DHA endogenously. These metabolic processes are somewhat more efficient during pregnancy and infancy compared with other life stages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/2\">",
"     2",
"    </a>",
"    ]. However, our ability to produce sufficient DHA for optimal health and development is probably inadequate; thus, consumption of preformed n-3 LCPUFAs, such as in fish, is recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Fish also contains other beneficial nutrients, such as iodine, vitamin D, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, fish may be contaminated by environmental pollutants, such as methylmercury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/4\">",
"     4",
"    </a>",
"    ]. Because of the health risks associated with methylmercury, the United States Food and Drug Administration (FDA) and Environmental Protection Agency have recommended that women of childbearing age, pregnant women, and breastfeeding mothers limit their intake of fish, and avoid all consumption of some types of fish (",
"    <a class=\"graphic graphic_table graphicRef53648 \" href=\"mobipreview.htm?16/25/16795\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the nutritional benefits and contaminant risks of maternal fish consumption during pregnancy. Issues related to the health effects of fish consumption in the general population are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/30/36330?source=see_link\">",
"     \"Fish oil and marine omega-3 fatty acids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     POTENTIAL BENEFITS",
"    </span>",
"    &nbsp;&mdash;&nbsp;One potential benefit of prenatal and postnatal n-3 LCPUFA intake relates to neurodevelopmental outcomes in offspring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Neurodevelopment",
"    </span>",
"    &nbsp;&mdash;&nbsp;DHA is a necessary structural component of the brain and eye. Because the uptake of DHA into the brain is greatest in the third trimester and first two years of life, the pre- and post-natal periods may represent an important window for exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Evidence from animal studies has demonstrated that diets deficient in n-3 fatty acids through pregnancy and lactation result in visual, cognitive, and behavioral deficits in the offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/8\">",
"     8",
"    </a>",
"    ]. In humans, some data from randomized trials suggest that n-3 LCPUFA supplements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/9-11\">",
"     9-11",
"    </a>",
"    ] during these periods have modest beneficial effects on neurodevelopmental and cognitive outcomes of offspring compared to controls. The lower magnitude of effect in human studies is likely because human control groups have generally not been as deficient in n-3 LCPUFA as animal controls. Prospective cohort studies also support a potential benefit: these studies have consistently observed that greater maternal prenatal fish consumption is associated with improved offspring neurodevelopment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]. However, these data are limited by several factors, including relatively high rates of drop-out and loss to follow-up, difficulties in accurately measuring seafood consumption (type, quantity), and confounders (eg, seafood intake as a marker of healthy lifestyle; maternal education, socioeconomic status, smoking, and alcohol use). It is possible that high fish consumption is only an indirect marker of other factors associated with a good neurodevelopmental outcome.",
"   </p>",
"   <p>",
"    Although increasing fish consumption increases fetal exposure to n-3 LCPUFA, it also can increase fetal exposure to methylmercury and its adverse neurodevelopmental effects (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Potential harms'",
"    </a>",
"    below). This two-edged sword is the basis of the current controversy regarding optimal fish intake for pregnant women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Prenatal fish oil supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 2013 meta-analysis including 11 randomized trials with a total of 5272 participants attempted to determine the effect of maternal omega-3 LCPUFA supplementation during pregnancy on neurologic and visual development in offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/16\">",
"     16",
"    </a>",
"    ]. Most of the trials had methodologic limitations, and the authors concluded the available evidence did not conclusively support or refute that omega-3 LCPUFA supplementation in pregnancy improves cognitive or visual development.",
"   </p>",
"   <p>",
"    The following individual studies represent examples of available data.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One group randomly assigned pregnant women to consume a cod liver oil supplement (n-3 LCPUFA) or a corn oil supplement (n-6 LCPUFA control) from 18 weeks of gestation until three months postpartum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/10\">",
"       10",
"      </a>",
"      ]. At age 4 years, offspring of the cod liver oil group had significantly higher scores on developmental and cognitive tests than the control group (106.4 (7.4) versus 102.3 (11.3) points on a mental processing test).",
"      <br/>",
"      <br/>",
"      At age 7 years, there were no differences between groups in test scores [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/17\">",
"       17",
"      </a>",
"      ]. However, maternal plasma phospholipid concentrations of alpha-linolenic acid (18:3n-3) and docosahexaenoic acid during pregnancy correlated with sequential processing at 7 years of age. The high drop-out rate was a limitation of this study.",
"     </li>",
"     <li>",
"      A similar trial compared offspring of mothers randomly assigned to a fish or olive oil supplement during pregnancy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/11\">",
"       11",
"      </a>",
"      ]. Offspring of the fish oil group had significantly higher scores on tests of eye and hand coordination (114 (10.2) versus 108 (11.3)), but no significant differences on other outcomes, including child behavior and language at age 2.5 years. Eye and hand coordination scores correlated with n-3 LCPUFA levels in cord blood erythrocytes and inversely correlated with n-6 LCPUFA levels. Limitations of the study were the small sample size so it was not powered to detect a modest difference.",
"     </li>",
"     <li>",
"      The DHA to Optimize Mother Infant Outcome (DOMInO) trial randomly assigned 2399 women less than 21 weeks of gestation to daily consumption of capsules containing 800 mg DHA or vegetable oil capsules [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/18\">",
"       18",
"      </a>",
"      ]. Despite improvements in rates of preterm birth, there were no differences between groups in visual function at 4 months of age, or in cognitive and language skills at 18 months of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the NUHEAL (Nutraceuticals for a Healthier Life) cohort, healthy pregnant women in three European centers were randomly assigned to receive a daily supplement of 500 mg docosahexaenoic acid (DHA) + 150 mg eicosapentaenoic acid (fish oil [FO]) or placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]. Infants received either formula supplemented with n-3 LCPUFA if they were born to mothers receiving FO supplements, or unsupplemented formula if they belonged to the placebo group. At 5 to 6 years of age, there were no differences in cognitive test scores or neurologic functioning between intervention groups. However, higher DHA in maternal erythrocyte at delivery was associated with improved mental processing and neurologic function in the offspring, which led the authors to conclude that maternal DHA status may be related to better neurological outcomes among children.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Prenatal fish consumption",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following individual studies represent examples of available data.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Data from a prospective pre-birth cohort study (Project Viva) based in eastern Massachusetts were used to examine the associations among maternal prenatal fish intake, maternal hair mercury levels, and cognitive development of offspring at 6 months to 3 years of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. Greater maternal fish consumption was associated with higher infant and child cognitive scores. The highest test scores were among children whose mothers consumed more than two weekly fish servings and had low mercury levels. Additional adjustment for mercury levels strengthened the beneficial association of fish consumption with offspring cognition, suggesting that the benefits of prenatal fish consumption might be even greater in the absence of mercury contamination (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Potential harms'",
"      </a>",
"      below). The authors proposed that women should continue to consume fish during pregnancy, but should avoid fish most highly contaminated with mercury to gain the greatest possible benefit.",
"     </li>",
"     <li>",
"      Among a cohort of over 25,000 mothers and children in Denmark, the highest versus the lowest quintile of fish intake was associated with higher child developmental scores at 18 months (OR 1.29, 95% CI 1.20-1.38) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Maternal seafood consumption in pregnancy and neurodevelopmental outcomes were evaluated using data from the Avon Longitudinal Study of Parents and Children (ALSPAC) study, which included 11,875 mothers and children from the United Kingdom [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/15\">",
"       15",
"      </a>",
"      ]. Compared with mothers who ate more than 340 g (12 ounces) of seafood per week, those who ate less seafood had a higher risk of having children with suboptimal scores on measures of verbal IQ, prosocial behavior, fine motor skills, and social development from ages 6 months to 8 years.",
"     </li>",
"     <li>",
"      In another UK study, at age 9 years, children of mothers who had eaten oily fish in late pregnancy had a reduced risk of hyperactivity (OR 0.34, 95% CI 0.15-0.78) and a higher verbal IQ (+7.6 points, 95% CI 0.75-14.4), but no difference in full-scale IQ, compared with those whose mothers did not eat fish [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a cohort of children in New York City, maternal fish consumption was associated with better psychomotor development (+8.7 points) at 36 months and higher verbal and full IQ scores at 48 months of age (+5.6 points for each) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among Inuit children in Canada, higher cord blood DHA levels were associated with improved memory function in school-age children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Breast milk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast milk is a rich source of long-chain fatty acids, whereas, before 2002, commercial infant formulas in the United States contained ALA, but no long-chain fatty acids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/25\">",
"     25",
"    </a>",
"    ]. It has been hypothesized that breastfed infants have better cognitive development than formula fed infants because of greater exposure to long-chain fatty acids during early postnatal brain development.",
"   </p>",
"   <p>",
"    One meta-analysis of observational studies found a three to five point increase in IQ among children who had been fed breast milk compared to those fed with infant formula (unsupplemented with long-chain fatty acids) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/26\">",
"     26",
"    </a>",
"    ]; however, the extent to which confounding explains these results is a major issue.",
"   </p>",
"   <p>",
"    The possible effect of confounding was illustrated in a subsequent analysis that concluded breastfeeding had little or no effect on intelligence and that IQ differences reported in observational studies were due to the effect of higher maternal IQs among women who chose to breastfeed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/27\">",
"     27",
"    </a>",
"    ]. However, an analysis among upper and middle income populations with different confounding structures provided evidence that the effect of breastfeeding on child IQ is causal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A large cluster-randomized trial attempted to control for confounders by comparing children delivered in hospitals randomly assigned to a promotion of breastfeeding program to those born in hospitals randomly assigned to maintain usual care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/29\">",
"     29",
"    </a>",
"    ]. Compared to usual care, hospitals that encouraged breastfeeding had a significant increase in the proportion of mothers who exclusively breastfed at three months (43 versus 6 percent) and who breastfed to any degree at one year (19.7 versus 11.4 percent). Children born in the intervention hospitals had higher verbal IQ +7.5 (95% CI +0.8 to +14.3), performance IQ +2.9 (95% CI -3.3 to +9.1), and full scale IQ +5.9 (95% CI -1.0 to +12.8) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/29\">",
"     29",
"    </a>",
"    ]. A limitation of this study is that the outcome assessors were not blinded. In addition, it did not address whether the long-chain fatty acid content of breast milk or one or more of the other characteristics of breastfeeding accounted for the observed benefits in offspring. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/47/32505?source=see_link&amp;anchor=H15#H15\">",
"     \"Infant benefits of breastfeeding\", section on 'Long-term benefits'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Formula supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2002, infant formula containing n-3 and n-6 long chain fatty acids (n-3 and n-6 LCPUFA) became available in the United States. Several randomized trials attempted to determine whether use of these supplemented infant formulas was associated with improved outcomes compared with unsupplemented formula. Meta-analyses of these randomized controlled trials did not find evidence of persistent beneficial effects of LCPUFA supplementation of formula milk on the physical, visual, and neurodevelopmental outcomes of term or preterm infants followed up to 3 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. This suggests that the beneficial effects of breastfeeding described above were related to factors other than the elongated fatty acid content of breast milk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other outcomes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Preterm birth",
"      </strong>",
"      &mdash; The effect of n-3 LCPUFA on preterm birth is unclear; some randomized trials have reported a reduction in early or late preterm birth, but the results have not been consistent across trials. The effect is likely to be no more than modest. These trials are described in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11994?source=see_link&amp;anchor=H17#H17\">",
"       \"Prevention of spontaneous preterm birth\", section on 'Nutritional intervention'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Allergy",
"      </strong>",
"      &mdash; Both a meta-analysis of two randomized trials and a subsequently published randomized trial reported that maternal prenatal n-3 LCPUFA supplementation was associated with a statistical reduction in positive skin prick tests (sensitization) to eggs in offspring tested up to 12 months of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. However, neither the meta-analysis nor the subsequent trial observed a significant reduction in food allergy (both allergic symptoms following ingestion and sensitization). In risk-adjusted analysis, rates of",
"      <span class=\"nowrap\">",
"       eczema/atopic",
"      </span>",
"      dermatitis were not significantly different in offspring of supplemented and unsupplemented women.",
"      <br/>",
"      <br/>",
"      The meta-analysis also noted a reduction in the prevalence of asthma in offspring of supplemented women",
"      <span class=\"nowrap\">",
"       (10/303",
"      </span>",
"      [3.3 percent] versus",
"      <span class=\"nowrap\">",
"       17/179",
"      </span>",
"      [9.5 percent], OR 0.35, 95% CI 0.15 to 0.79) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/32\">",
"       32",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      More data are needed before a clinical recommendation can be made about prenatal n-3 LCPUFA supplementation for prevention of childhood allergic conditions. The available data are limited by small sample size, wide confidence intervals, and heterogeneity in study populations and designs. &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Peripartum depression",
"      </strong>",
"      &mdash; Although an observational study reported reduced risks of peripartum depression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/34\">",
"       34",
"      </a>",
"      ], a large multicenter randomized trial and another observational study found no benefit [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/18,35\">",
"       18,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Preeclampsia",
"      </strong>",
"      &mdash; Despite some promising evidence from observational studies, randomized trials of fish oil supplements have not shown efficacy in preventing preeclampsia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41609?source=see_link\">",
"       \"Prevention of preeclampsia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Gestational diabetes",
"      </strong>",
"      &mdash; In a randomized trial, DHA supplementation of 800",
"      <span class=\"nowrap\">",
"       mg/d",
"      </span>",
"      in the second half of pregnancy did not reduce the risk of developing gestational diabetes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     POTENTIAL HARMS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Methylmercury toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mercury is a ubiquitous heavy metal with both natural and anthropogenic sources. The toxic effects of high-dose exposure are well documented [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34295?source=see_link\">",
"     \"Epidemiology and toxicity of mercury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/40/4746?source=see_link\">",
"     \"Occupational and environmental risks to reproduction in females\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are three types of mercury in the environment: elemental, inorganic, and organic. The primary source of non-occupational mercury exposure is consumption of fish and other seafood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. The mercury found in fish is nearly all the organic form, as methylmercury. It is over 95 percent absorbed when consumed, and can penetrate every cell in the body. It cannot be cooked out of the fish, as it is strongly bound in tissues.",
"   </p>",
"   <p>",
"    Whereas adult exposure to mercury can cause localized damage to discrete areas of the brain, exposure in fetal life causes diffuse and widespread neurological damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/40\">",
"     40",
"    </a>",
"    ]. Thus, the fetal brain is considered the tissue most sensitive to the harms of mercury. The particular sensitivity of the fetus to toxic effects from organic mercury exposure were revealed as a result of episodes of community-wide mercury poisoning in Japan (Minamata disease) and Iraq [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Pregnant women exposed to organic mercury in these communities developed no or minimal symptoms themselves, but had babies with delayed attainment of developmental milestones and, in some cases, devastating neurological handicaps, including blindness, deafness, and cerebral palsy.",
"   </p>",
"   <p>",
"    Elemental or ionic mercury is released into the environment from natural processes such as volcanic eruptions, and from human activities such as burning coal for energy and incineration of medical or other waste containing mercury. This inorganic mercury may ultimately make its way to the watershed, where it is methylated by microorganisms. Once organified, methylmercury is readily absorbed by marine life, and bioaccumulates and biomagnifies as it ascends the aquatic food chain. Although most fish contain at least some mercury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/37,38\">",
"     37,38",
"    </a>",
"    ], the highest mercury concentrations are found in animals at the highest trophic levels (ie, feeding position in a food chain including long-lived predatory species such as sharks, swordfish, and tuna) and in individuals that have lived the longest.",
"   </p>",
"   <p>",
"    An estimated 95 percent of ingested methylmercury is absorbed into the bloodstream, readily crossing both the blood-brain barrier and the placenta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/4,37\">",
"     4,37",
"    </a>",
"    ]. Mercury is distributed throughout all body tissues, unlike other contaminants such as polychlorinated biphenyls (PCBs), which are concentrated in adipose tissue and organ meats. The half-life is about 70 days in the blood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/37,43\">",
"     37,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the 1970s and 1980s, longitudinal prospective studies were initiated in island populations to evaluate the effects of methylmercury exposure from habitual fish consumption during pregnancy. Results from cohorts in New Zealand and the Faroe Islands suggested that higher prenatal methylmercury exposure from seafood consumption was associated with decrements in attention, language, verbal memory, motor speed, and visuospatial function in offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. These findings prompted recommendations for pregnant women to limit fish consumption. A similar cohort study in the Seychelle Islands found no harmful effect of prenatal methylmercury exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/47\">",
"     47",
"    </a>",
"    ]. However, in another smaller Seychelles cohort, an adverse association was observed between maternal hair mercury levels and child Psychomotor Developmental Index score at 30 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    None of these studies initially included an estimate of the overall effect of maternal prenatal fish consumption on child development. When investigators from the Faroe Islands subsequently reanalyzed their data to better estimate the independent effects of seafood intake and mercury exposure, they found that maternal seafood intake was associated with better motor and spatial function in children at age 14 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/49\">",
"     49",
"    </a>",
"    ]. Additionally, in the Seychelles cohort, as prenatal methylmercury exposure increased, the investigators observed improved performance on 4 of 27 endpoints at age 17 years, including a reduction in behavioral problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/50\">",
"     50",
"    </a>",
"    ]. This finding supports the beneficial role of nutrients present in fish.",
"   </p>",
"   <p>",
"    Fish also contains",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    . While some evidence suggests that the selenium may counteract the toxic effects of mercury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/51\">",
"     51",
"    </a>",
"    ], this literature mainly includes animal and in vitro studies. Further investigation is needed to determine whether selenium is protective in humans.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other contaminants in fish",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fish, especially the fatty tissues, may also be contaminated with persistent organic pollutants (POPs) including polychlorinated biphenyls (PCBs), brominated flame retardants, and dioxins. Exposure to these contaminants has been declining steadily since the 1970s, when government regulations reduced industrial emissions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/52\">",
"     52",
"    </a>",
"    ], but some exposure persists. It should be noted that more than 90 percent of exposure to POPs occurs from exposure to foods other than fish [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/53\">",
"     53",
"    </a>",
"    ]. Evidence for adverse health effects associated with POP exposure during pregnancy has been inconsistent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/40/4746?source=see_link\">",
"     \"Occupational and environmental risks to reproduction in females\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PATIENT COUNSELING",
"    </span>",
"    &nbsp;&mdash;&nbsp;On the basis of the available data, expert panels worldwide have recommended that pregnant and lactating women should aim to achieve an average dietary DHA intake of at least 200 to 300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    to support optimal visual and cognitive development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/3,54-56\">",
"     3,54-56",
"    </a>",
"    ]. Most women do not consume this amount. In the 1999-2002 National Health and Nutrition Examination (NHANES) Survey, mean DHA intake was 73",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    among pregnant women, and 62",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    among women of childbearing age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sources of DHA include fish, supplements, and fortified foods. Since fish is the only food in which n-3 long-chain fatty acids occur in abundance, regular fish consumption is the only way for women to achieve adequate DHA intake without using a supplement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/3\">",
"     3",
"    </a>",
"    ]. Intake of one to two weekly servings of oily fish achieves the goal of 200",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Seafood that are high in n-3 long-chain fatty acids include anchovies, Atlantic herring, Atlantic mackerel, mussels, oysters, farmed and wild salmon, sardines, snapper, trout, and canned white tuna [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/57,58\">",
"     57,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most commonly eaten fish types in the US that are low in mercury (shrimp, salmon, pollock, and catfish) vary considerably in their content of DHA. Thus, consumption of 12 weekly ounces will provide different amounts of DHA depending on the type of fish consumed (shrimp 70",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    DHA, farm-raised salmon 707",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    DHA, wild salmon 694",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    DHA, pollock 218",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    DHA, catfish 62",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    DHA).",
"   </p>",
"   <p>",
"    Supplements containing either fish oil or DHA synthesized by algae are also available in a variety of doses, and include formulations marketed for pregnant women. These supplements have generally been found to be low in mercury and other contaminants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Additionally, a number of foods fortified with DHA are now available, including yogurt, milk, and eggs.",
"   </p>",
"   <p>",
"    Although it is possible for pregnant women to achieve recommended DHA intake via supplements or fortified foods, most experts recommend regular fish consumption when possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/3\">",
"     3",
"    </a>",
"    ]. In its 2006 report, \"Seafood Choices: Balancing Risks and Benefits,\" the Institute of Medicine concluded that seafood is a component of a healthy diet, although women should try to avoid consuming fish high in mercury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/1\">",
"     1",
"    </a>",
"    ]. The American Dietetic Association and Dietitians of Canada also reinforced the importance of a food-based approach for meeting dietary fatty acid recommendations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/61\">",
"     61",
"    </a>",
"    ]. However, pregnant women in Massachusetts who participated in focus groups reported that they received no advice to consume fish as a way to increase DHA intake during pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the variability in fish mercury content, some mercury exposure will be inevitable if fish are consumed. It is not possible to completely eliminate this risk without eliminating fish consumption. The beneficial effects of n-3 LCPUFAs and other nutrients in fish for child neurocognitive development may counteract or outweigh the potential harmful effects of small amounts of methylmercury, especially when fish low in mercury are consumed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Fish intake guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;The DHA and mercury content of fish vary independently, so that several options are available that are both low in mercury and high in DHA. In 2001, the US Environmental Protection Agency and Food and Drug Administration issued a joint consumer advisory recommending that pregnant women avoid consuming fish types high in mercury (shark, tilefish, swordfish, and king mackerel), and limit their total fish intake to no more than two 6 ounce servings per week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/63\">",
"     63",
"    </a>",
"    ]. In 2004, a revised US federal advisory also included advice encouraging women to eat a variety of fish types up to two weekly servings, with some additional guidance about albacore tuna (",
"    <a class=\"graphic graphic_table graphicRef53648 \" href=\"mobipreview.htm?16/25/16795\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. The Environmental Protection Agency also publishes online fish consumption advice for locally caught fish in each US state and territory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These advisories were based on the Environmental Protection Agency's reference dose for methylmercury, but did not incorporate any information about the nutrient contents of different types of fish, and did not include guidance on achieving recommended intake of DHA. The Food and Drug Administration (FDA) is currently revisiting these advisories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not clear whether advisories are effective in achieving a reduction in mercury exposure without adversely reducing fish or DHA intake. In a time-series analysis among a cohort of pregnant women, some surveyed before dissemination of the January 2001 mercury advisory, and others surveyed afterwards, average total fish intake decreased after publication of the advisory by about 1.4 monthly servings, a 17 percent decline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/68\">",
"     68",
"    </a>",
"    ]. Women surveyed after the advisory ate fewer fish servings, not only of the dark meat fish likely to have higher mercury contamination, but also of fish types not specifically named in the advisory and likely to be lower in mercury. Similarly, an analysis of household-level consumer panel data from 15,000 US households found that at-risk consumers reduced fish intake in 2000-2002, resulting in declines in both mercury and n-3 intakes across the entire distribution, including those with already low intake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/69\">",
"     69",
"    </a>",
"    ]. Consumers did not differentially avoid high mercury fish, nor did they replace high mercury fish with low mercury, high omega-3 species.",
"   </p>",
"   <p>",
"    However, other advisories have not achieved intended effects. Administration of a fish consumption advisory to women in France resulted in reduced consumption of tuna fish, but no change in intake of the most highly contaminated fish [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/70\">",
"     70",
"    </a>",
"    ]. After dissemination of a sport fish advisory in Wisconsin, advisory awareness had no effect on mercury exposure among women who ate sportfish [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to ensure that advisories lead to desired behavior changes and no undesired changes. Classically, simple public health messages are the most effective, such as \"don't smoke.\" However, in this circumstance, it appears that a more nuanced approach is necessary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/62\">",
"     62",
"    </a>",
"    ]. Women who may become pregnant, are currently pregnant, or breastfeeding should avoid high mercury fish, while continuing regular consumption of fish that is low in mercury and high in n-3 LCPUFA. If women are not able or willing to consume fish, they should seek out another source of n-3 PUFA. Total avoidance of fish consumption, without another source of DHA intake, may result in unfavorable effects by depriving the developing fetal brain of an essential nutrient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Estimating mercury intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;The US Environmental Protection Agency relied on the National Research Council's (NRC) analysis to derive its Reference Dose (RfD) of 0.1 mcg",
"    <span class=\"nowrap\">",
"     methylmercury/kg",
"    </span>",
"    body",
"    <span class=\"nowrap\">",
"     weight/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/72\">",
"     72",
"    </a>",
"    ]. The reference dose is an estimate (with uncertainty spanning about an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime.",
"   </p>",
"   <p>",
"    Information on mercury levels in fish can be used to estimate mercury intake. The FDA publishes reference levels for mercury in commercial fish and shellfish, although estimates may be based on as few as two fish samples (",
"    <a class=\"graphic graphic_table graphicRef63441 \" href=\"mobipreview.htm?39/42/40622\">",
"     table 2",
"    </a>",
"    ). Based on these measurements, fish can be ranked by their mercury content: low, below average, above average, moderately high, high, or very high [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/73\">",
"     73",
"    </a>",
"    ]. A 2012 publication provides a database of mercury concentrations in fish and shellfish common to the United States market based on a much larger foundation of data aggregated from government monitoring programs and the scientific literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Online mercury calculators are available (eg,",
"    <a class=\"external\" href=\"file://www.gotmercury.org/\">",
"     www.gotmercury.org",
"    </a>",
"    ) that allow individuals to estimate their mercury exposure.",
"   </p>",
"   <p>",
"    A limitation of these methods is the variability in the mercury content of fish. For example, the mean concentration of mercury in canned light tuna is 0.118 ppm",
"    <span class=\"nowrap\">",
"     (mcg/g),",
"    </span>",
"    with a range from 0 to 0.852 ppm. Thus, a 60 kg woman consuming 100 g (about 3.5 oz) of canned light tuna per week would on average get 0.028 mcg",
"    <span class=\"nowrap\">",
"     mercury/kg",
"    </span>",
"    body weight per week (30 percent of the reference dose); but could get none (0 percent of the reference dose), or could get as much as 0.20",
"    <span class=\"nowrap\">",
"     mcg/kg/week",
"    </span>",
"    (200 percent of the reference dose).",
"   </p>",
"   <p>",
"    While this amount of mercury exposure may exceed the Environmental Protection Agency's reference dose, other regulatory agencies have made different recommendations regarding intake limits for methylmercury. The US Agency for Toxic Substances and Disease Registry derived a Minimal Risk Level of 0.3 mcg",
"    <span class=\"nowrap\">",
"     methylmercury/kg",
"    </span>",
"    body",
"    <span class=\"nowrap\">",
"     weight/day",
"    </span>",
"    (three-fold higher) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/75\">",
"     75",
"    </a>",
"    ]; the World Health Organization's Joint Expert Committee on Food Additives and Contaminants derived a Provisional Tolerable Intake of 0.23 mcg",
"    <span class=\"nowrap\">",
"     /kg/day",
"    </span>",
"    (2.3-fold higher) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/76\">",
"     76",
"    </a>",
"    ]; and the Canadian Bureau of Chemical Safety recommended a Provisional Tolerable Intake of 0.20",
"    <span class=\"nowrap\">",
"     mcg/kg/day",
"    </span>",
"    (two-fold higher) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Clinical measurement of mercury levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine screening of mercury levels in the general population is not recommended. Clinicians or patients may elect to test if the patient is at risk because of symptoms or because of frequent consumption of fish likely to be higher in mercury. In asymptomatic women, we usually assess diet and advise changes as needed.",
"   </p>",
"   <p>",
"    Appropriate biomarkers of methylmercury exposure include hair and whole blood. Urinary mercury levels primarily reflect inorganic exposure, such as from dental amalgam, and are not an appropriate biomarker for dietary organic mercury exposure. Individuals who have elevated mercury levels should be advised to lower their intake of mercury containing fish. In a case series of high end fish consumers, mercury levels declined rapidly in the first three weeks after advice to reduce fish intake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In their analysis of the Toxicologic Effects of Methylmercury, the NRC estimated a benchmark mercury \"dose\" of 85 parts per billion (ppb) of blood, or 17 parts per million (ppm) of hair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/4\">",
"     4",
"    </a>",
"    ]. The NRC based this estimate on the dose at which there was a doubling of the proportion of abnormal responses on the Boston Naming Test, the most sensitive test to the effects of prenatal mercury exposure in the Faroe Islands study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/45\">",
"     45",
"    </a>",
"    ]. The NRC recommended using the lower 95 percent confidence limit of the benchmark dose, corresponding to 58 ppb of blood, or 12 ppm of hair, and adding an uncertainty factor of 10 (ie, setting a threshold 10 times lower than the 95% CI of the benchmark dose), to account for variability in metabolism and sensitive subgroups.",
"   </p>",
"   <p>",
"    Based on this rationale, mercury levels can be considered elevated when they exceed 5.8 ppb of blood (the 95% CI 58 divided by 10), or 1.2 ppm of hair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/79\">",
"     79",
"    </a>",
"    ]. Most laboratories measure total mercury; approximately 90 percent of the mercury in the body exists as methylmercury. In the National Health and Nutrition Examination Survey (NHANES) 1999-2004, the proportion of women of childbearing age with blood mercury above 5.8 ppb ranged from 1.2 percent in Midwestern US to 9.3 percent in the Northeastern US [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/80\">",
"     80",
"    </a>",
"    ]. Women living in coastal or urban areas, with higher income, and of Asian ethnicity tended to have higher levels, because of their greater fish intake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33273/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fish is the primary dietary source of two n-3 (also known as omega-3) long chain polyunsaturated fatty acids (n-3 LCPUFAs): docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). The body's ability to produce sufficient DHA for optimal health and development is probably inadequate; therefore, consumption of preformed n-3 LCPUFAs, such as in fish, is recommended. However, fish may be contaminated by environmental pollutants, such as methylmercury. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      DHA is a necessary structural component of the brain and eye. Fish consumption during the prenatal and early postnatal periods appears to have modest beneficial effects on neurodevelopmental and cognitive outcome of offspring. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Potential benefits'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intake of one to two weekly servings of fish, preferably oily fish, achieves the DHA intake goal of 200",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Patient counseling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that women who may become pregnant, are currently pregnant, or breastfeeding consume one to two weekly servings of fish high in n-3 LCPUFA and low in mercury (",
"      <a class=\"graphic graphic_table graphicRef53648 \" href=\"mobipreview.htm?16/25/16795\">",
"       table 1",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). This means not eating shark, swordfish, king mackerel, or tilefish because they contain high levels of mercury. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Patient counseling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The fetal brain is considered the tissue most sensitive to the harms of mercury, thus maternal consumption of fish with potentially high levels of mercury, or very frequent consumption of fish with moderate levels of mercury, should be avoided (",
"      <a class=\"graphic graphic_table graphicRef53648 \" href=\"mobipreview.htm?16/25/16795\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Potential harms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no clear evidence that n-3 PUFA supplements during pregnancy improve offspring neurodevelopment, although supplement use may reduce risk for preterm birth. For pregnant women who are not able or willing to consume fish, we suggest other sources of n-3 PUFA to achieve an intake of 200",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of DHA (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Patient counseling'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Seafood Choices: Balancing benefits and risks, Nesheim, M, Yaktine, A (Eds), The National Academy Press, Washington, DC 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/2\">",
"      Brenna JT, Salem N Jr, Sinclair AJ, et al. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009; 80:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/3\">",
"      Koletzko B, Cetin I, Brenna JT, et al. Dietary fat intakes for pregnant and lactating women. Br J Nutr 2007; 98:873.",
"     </a>",
"    </li>",
"    <li>",
"     Goyer, R, Aposhian, V, Arab, L, et al. Toxicological effects of methylmercury, The National Academy Press, Washington, DC 2000.",
"    </li>",
"    <li>",
"     Environmental Protection Agency. 2004 FDA/EPA Consumer Advisory: What You Need to Know About Mercury in Fish and Shellfish. Available at: www.epa.gov/ost/fishadvice/factsheet.html. Environmental Protection Agency; 2004. (Accessed March 23, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/6\">",
"      Lewin GA, Schachter HM, Yuen D, et al. Effects of omega-3 fatty acids on child and maternal health. Evid Rep Technol Assess (Summ) 2005; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/7\">",
"      McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005; 82:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/8\">",
"      Brenna JT. Animal studies of the functional consequences of suboptimal polyunsaturated fatty acid status during pregnancy, lactation and early post-natal life. Matern Child Nutr 2011; 7 Suppl 2:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/9\">",
"      Hadders-Algra M, Bouwstra H, van Goor SA, et al. Prenatal and early postnatal fatty acid status and neurodevelopmental outcome. J Perinat Med 2007; 35 Suppl 1:S28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/10\">",
"      Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003; 111:e39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/11\">",
"      Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008; 93:F45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/12\">",
"      Oken E, Wright RO, Kleinman KP, et al. Maternal fish consumption, hair mercury, and infant cognition in a U.S. Cohort. Environ Health Perspect 2005; 113:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/13\">",
"      Oken E, Radesky JS, Wright RO, et al. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol 2008; 167:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/14\">",
"      Oken E, &Oslash;sterdal ML, Gillman MW, et al. Associations of maternal fish intake during pregnancy and breastfeeding duration with attainment of developmental milestones in early childhood: a study from the Danish National Birth Cohort. Am J Clin Nutr 2008; 88:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/15\">",
"      Hibbeln JR, Davis JM, Steer C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007; 369:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/16\">",
"      Gould JF, Smithers LG, Makrides M. The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2013; 97:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/17\">",
"      Helland IB, Smith L, Blom&eacute;n B, et al. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 2008; 122:e472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/18\">",
"      Makrides M, Gibson RA, McPhee AJ, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010; 304:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/19\">",
"      Smithers LG, Gibson RA, Makrides M. Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. Am J Clin Nutr 2011; 93:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/20\">",
"      Campoy C, Escolano-Margarit MV, Ramos R, et al. Effects of prenatal fish-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6.5 y of age. Am J Clin Nutr 2011; 94:1880S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/21\">",
"      Escolano-Margarit MV, Ramos R, Beyer J, et al. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. J Nutr 2011; 141:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/22\">",
"      Gale CR, Robinson SM, Godfrey KM, et al. Oily fish intake during pregnancy--association with lower hyperactivity but not with higher full-scale IQ in offspring. J Child Psychol Psychiatry 2008; 49:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/23\">",
"      Lederman SA, Jones RL, Caldwell KL, et al. Relation between cord blood mercury levels and early child development in a World Trade Center cohort. Environ Health Perspect 2008; 116:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/24\">",
"      Boucher O, Burden MJ, Muckle G, et al. Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age. Am J Clin Nutr 2011; 93:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/25\">",
"      AAP Committee on Nutrition. New infant formula additives approved by FDA. AAP News 2002; 20:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/26\">",
"      Anderson JW, Johnstone BM, Remley DT. Breast-feeding and cognitive development: a meta-analysis. Am J Clin Nutr 1999; 70:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/27\">",
"      Der G, Batty GD, Deary IJ. Effect of breast feeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis. BMJ 2006; 333:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/28\">",
"      Brion MJ, Lawlor DA, Matijasevich A, et al. What are the causal effects of breastfeeding on IQ, obesity and blood pressure? Evidence from comparing high-income with middle-income cohorts. Int J Epidemiol 2011; 40:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/29\">",
"      Kramer MS, Aboud F, Mironova E, et al. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry 2008; 65:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/30\">",
"      Simmer K, Patole SK, Rao SC. Long-chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008; :CD000376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/31\">",
"      Simmer K, Schulzke SM, Patole S. Long-chain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2008; :CD000375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/32\">",
"      Klemens CM, Berman DR, Mozurkewich EL. The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG 2011; 118:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/33\">",
"      Palmer DJ, Sullivan T, Gold MS, et al. Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ 2012; 344:e184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/34\">",
"      Golding J, Steer C, Emmett P, et al. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 2009; 20:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/35\">",
"      Str&oslash;m M, Mortensen EL, Halldorsson TI, et al. Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: a prospective study based on a large national birth cohort. Am J Clin Nutr 2009; 90:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/36\">",
"      Zhou SJ, Yelland L, McPhee AJ, et al. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am J Clin Nutr 2012; 95:1378.",
"     </a>",
"    </li>",
"    <li>",
"     IPCS (International Program on Chemical Safety). Environmental Health Criteria 101: Methylmercury. World Health Organization, Geneva 1990.",
"    </li>",
"    <li>",
"     US Environmental Protection Agency. Mercury report to congress. Washington, DC 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/39\">",
"      Risher JF, Murray HE, Prince GR. Organic mercury compounds: human exposure and its relevance to public health. Toxicol Ind Health 2002; 18:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/40\">",
"      Castoldi AF, Coccini T, Ceccatelli S, Manzo L. Neurotoxicity and molecular effects of methylmercury. Brain Res Bull 2001; 55:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/41\">",
"      Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 1995; 25:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/42\">",
"      Amin-Zaki L, Elhassani S, Majeed MA, et al. Intra-uterine methylmercury poisoning in Iraq. Pediatrics 1974; 54:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/43\">",
"      Clarkson TW, Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 2006; 36:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/44\">",
"      Crump KS, Kjellstr&ouml;m T, Shipp AM, et al. Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal 1998; 18:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/45\">",
"      Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997; 19:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/46\">",
"      Debes F, Budtz-J&oslash;rgensen E, Weihe P, et al. Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol Teratol 2006; 28:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/47\">",
"      Myers GJ, Davidson PW, Cox C, et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 2003; 361:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/48\">",
"      Davidson PW, Strain JJ, Myers GJ, et al. Neurodevelopmental effects of maternal nutritional status and exposure to methylmercury from eating fish during pregnancy. Neurotoxicology 2008; 29:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/49\">",
"      Budtz-J&oslash;rgensen E, Grandjean P, Weihe P. Separation of risks and benefits of seafood intake. Environ Health Perspect 2007; 115:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/50\">",
"      Davidson PW, Cory-Slechta DA, Thurston SW, et al. Fish consumption and prenatal methylmercury exposure: cognitive and behavioral outcomes in the main cohort at 17 years from the Seychelles child development study. Neurotoxicology 2011; 32:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/51\">",
"      Ralston NV, Ralston CR, Blackwell JL 3rd, Raymond LJ. Dietary and tissue selenium in relation to methylmercury toxicity. Neurotoxicology 2008; 29:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/52\">",
"      Aylward LL, Hays SM. Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levels. J Expo Anal Environ Epidemiol 2002; 12:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/53\">",
"      Mozaffarian D. Fish, mercury, selenium and cardiovascular risk: current evidence and unanswered questions. Int J Environ Res Public Health 2009; 6:1894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/54\">",
"      Simopoulos AP, Leaf A, Salem N Jr. Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2000; 63:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/55\">",
"      Koletzko B, Lien E, Agostoni C, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008; 36:5.",
"     </a>",
"    </li>",
"    <li>",
"     March of Dimes. Omega?3 Fatty Acids During Pregnancy. March of Dimes Web Site, 2009. Available at file://www.marchofdimes.com/pnhec/159_55030.asp. (Accessed June 17, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/57\">",
"      Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296:1885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/58\">",
"      Domingo JL, Bocio A, Falc&oacute; G, Llobet JM. Benefits and risks of fish consumption Part I. A quantitative analysis of the intake of omega-3 fatty acids and chemical contaminants. Toxicology 2007; 230:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/59\">",
"      Foran SE, Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med 2003; 127:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/60\">",
"      Melanson SF, Lewandrowski EL, Flood JG, Lewandrowski KB. Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature. Arch Pathol Lab Med 2005; 129:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/61\">",
"      Kris-Etherton PM, Innis S. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 2007; 107:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/62\">",
"      Bloomingdale A, Guthrie LB, Price S, et al. A qualitative study of fish consumption during pregnancy. Am J Clin Nutr 2010; 92:1234.",
"     </a>",
"    </li>",
"    <li>",
"     Food and Drug Administration. Consumer advisory: An important message for pregnant women and women of childbearing age who may become pregnant about the risks of mercury in fish. Available at: file://vm.cfsan.fda.gov/~dms/admehg.html. (Accessed July 17, 2007).",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. What you need to know about mercury in fish and shellfish. March 2004. Available at: file://www.cfsan.fda.gov/~dms/admehg3.html. (Accessed July 20, 2004).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/65\">",
"      Mahaffey KR, Clickner RP, Jeffries RA. Methylmercury and omega-3 fatty acids: co-occurrence of dietary sources with emphasis on fish and shellfish. Environ Res 2008; 107:20.",
"     </a>",
"    </li>",
"    <li>",
"     Environmental Protection Agency. Advisories where you live. file://www.epa.gov/waterscience/fish/states.htm. 2008;Last Updated November 18, 2008. (Accessed August 19, 2009).",
"    </li>",
"    <li>",
"     file://www.fda.gov/Food/FoodSafety/Product-SpecificInformation/Seafood/FoodbornePathogensContaminants/Methylmercury/ucm088758.htm (Accessed on November 18, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/68\">",
"      Oken E, Kleinman KP, Berland WE, et al. Decline in fish consumption among pregnant women after a national mercury advisory. Obstet Gynecol 2003; 102:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/69\">",
"      Shimshack JP, Ward MB. Mercury advisories and household health trade-offs. J Health Econ 2010; 29:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/70\">",
"      Verger P, Houdart S, Marette S, et al. Impact of a risk-benefit advisory on fish consumption and dietary exposure to methylmercury in France. Regul Toxicol Pharmacol 2007; 48:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/71\">",
"      Knobeloch L, Anderson HA, Imm P, et al. Fish consumption, advisory awareness, and hair mercury levels among women of childbearing age. Environ Res 2005; 97:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/72\">",
"      Rice DC, Schoeny R, Mahaffey K. Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA. Risk Anal 2003; 23:107.",
"     </a>",
"    </li>",
"    <li>",
"     Food and Drug Administration. Mercury Levels in Commercial Fish and Shellfish. file://www.fda.gov/Food/FoodSafety/Product-SpecificInformation/Seafood/FoodbornePathogensContaminants/Methylmercury/ucm115644.htm. 2009;Last Updated: 05/07/2009. (Accessed August 20, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/74\">",
"      Karimi R, Fitzgerald TP, Fisher NS. A quantitative synthesis of mercury in commercial seafood and implications for exposure in the United States. Environ Health Perspect 2012; 120:1512.",
"     </a>",
"    </li>",
"    <li>",
"     US Agency for Toxic Substances and Disease Registry. Toxicological Profile for Mercury. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 1999.",
"    </li>",
"    <li>",
"     FAO/WHO Joint Expert Committee on Food Additives. Evaluation of certain food additives and contaminants (Sixty-first report of the Joint FAO/WHO Expert Committee on Food Additives). WHO Technical Report Series 2004; No. 922.",
"    </li>",
"    <li>",
"     Health Canada. Human Health Risk Assessment of Mercury in Fish and Health Benefits of Fish Consumption. Ottawa: Health Canada; 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/78\">",
"      Hightower JM, Moore D. Mercury levels in high-end consumers of fish. Environ Health Perspect 2003; 111:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/79\">",
"      Mahaffey KR, Clickner RP, Bodurow CC. Blood organic mercury and dietary mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000. Environ Health Perspect 2004; 112:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33273/abstract/80\">",
"      Mahaffey KR, Clickner RP, Jeffries RA. Adult women's blood mercury concentrations vary regionally in the United States: association with patterns of fish consumption (NHANES 1999-2004). Environ Health Perspect 2009; 117:47.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 431 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-178.219.2.221-D2DE38DEA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33273=[""].join("\n");
var outline_f32_31_33273=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      POTENTIAL BENEFITS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Neurodevelopment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Prenatal fish oil supplements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Prenatal fish consumption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Breast milk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Formula supplements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      POTENTIAL HARMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Methylmercury toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other contaminants in fish",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PATIENT COUNSELING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Fish intake guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Estimating mercury intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Clinical measurement of mercury levels",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/431\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/431|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/25/16795\" title=\"table 1\">",
"      Seafood advisory for pregnant women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/42/40622\" title=\"table 2\">",
"      Mercury levels in seafood",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34295?source=related_link\">",
"      Epidemiology and toxicity of mercury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/30/36330?source=related_link\">",
"      Fish oil and marine omega-3 fatty acids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/47/32505?source=related_link\">",
"      Infant benefits of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/40/4746?source=related_link\">",
"      Occupational and environmental risks to reproduction in females",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41609?source=related_link\">",
"      Prevention of preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11994?source=related_link\">",
"      Prevention of spontaneous preterm birth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_31_33274="Surgical management of severe obesity";
var content_f32_31_33274=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of severe obesity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/31/33274/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/31/33274/contributors\">",
"     Robert A Andrews, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/31/33274/contributors\">",
"     Robert B Lim, MD, FACS, LTC, MC, USA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/31/33274/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/31/33274/contributors\">",
"     Daniel Jones, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/31/33274/contributors\">",
"     F Xavier Pi-Sunyer, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/31/33274/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/31/33274/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/31/33274/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 31, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity is defined as body mass index (BMI) &gt;30",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     .",
"    </span>",
"    Obesity is increasing in prevalence in the United States and worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Centers for Disease Control and Prevention (CDC) data on obesity show a steady and appreciable increase in obesity in the United States from 1985 to 2008 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/1\">",
"     1",
"    </a>",
"    ]. More than 33 percent of adults in the United States (approximately 72 million people) are obese [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Furthermore, more than 64 percent of Americans are overweight (BMI &ge;25",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     ).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/45/13016?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of therapy for obesity in adults\", section on 'Prevalence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The economic costs of obesity are staggering [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/2,6,7\">",
"     2,6,7",
"    </a>",
"    ]. The cost of treating obesity and its complications in the United States is approximately 100 billion dollars per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/6\">",
"     6",
"    </a>",
"    ]. Additionally, obesity and its complications lead to other significant costs, such as missed days of work and a decrease in life expectancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/2\">",
"     2",
"    </a>",
"    ]. Similar trends have been reported in other parts of the world [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/3,8\">",
"     3,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are several well-established health hazards associated with obesity, including type 2 diabetes, heart disease, stroke, certain cancers, osteoarthritis, liver disease, obstructive sleep apnea, and depression (",
"    <a class=\"graphic graphic_table graphicRef69532 \" href=\"mobipreview.htm?29/40/30347\">",
"     table 1",
"    </a>",
"    ). The risk of development of complications rises with increasing adiposity, while weight loss can reduce the risk. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are many behavioral, medical, and surgical options for achieving weight loss. Bariatric surgical procedures are increasingly common. Data from the Nationwide Inpatient Sample from 2003 through 2008 documented that the number of bariatric operations in the United States peaked in 2004 at 135,985 cases and plateaued at 124,838 cases in 2008 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will focus on surgical procedures, which have been collectively referred to as \"bariatric\" surgery (from the Greek words \"baros\" meaning \"weight\" and \"iatrikos\" meaning \"medicine\"). Complications of bariatric procedures are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link\">",
"     \"Complications of bariatric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The general approach to the management of obesity and clinical practice guidelines from the American College of Physicians for management of obesity in primary care are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/45/13016?source=see_link\">",
"     \"Overview of therapy for obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BODY MASS INDEX",
"    </span>",
"    &nbsp;&mdash;&nbsp;Body mass index (BMI) is considered to represent the most practical measure of a person's adiposity. It is calculated by dividing the weight in kilograms by the height in meters squared",
"    <span class=\"nowrap\">",
"     (kg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?39/41/40593?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). In adults, a BMI of:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      25 to 29.9",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      is considered overweight",
"     </li>",
"     <li>",
"      30 to 34.9",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      is considered obese (class I obesity)",
"     </li>",
"     <li>",
"      35 to 39.9",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      is considered moderately obese (class II obesity)",
"     </li>",
"     <li>",
"      40 to 49.9",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      is considered severely or extremely obese (class III obesity)",
"     </li>",
"     <li>",
"      &gt;50.0",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      is considered super obese (class IV obesity)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF WEIGHT LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bariatric surgical procedures affect weight loss through two fundamental mechanisms: (1) malabsorption and (2) restriction (",
"    <a class=\"graphic graphic_table graphicRef59447 \" href=\"mobipreview.htm?4/55/4987\">",
"     table 2",
"    </a>",
"    ). Some procedures have both a restrictive and malabsorptive component. There is also growing recognition that bariatric surgical procedures contribute to neurohormonal effects on the regulation of energy balance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/10-16\">",
"     10-16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Restrictive procedures limit caloric intake by reducing the stomach's reservoir capacity via resection, bypass or creation of a proximal gastric outlet. Vertical banded gastroplasty (VBG) and laparoscopic adjustable gastric banding (LAGB) are purely restrictive procedures, and share similar anatomical configurations. Both limit solid food intake by restriction of stomach size as the only mechanism of action, leaving the absorptive function of the small intestine intact. Although these procedures are simpler in comparison to malabsorptive procedures, they tend to produce more gradual weight loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Malabsorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malabsorptive procedures decrease the effectiveness of nutrient absorption by shortening the length of the functional small intestine, either through bypass of the small bowel absorptive surface area or diversion of the biliopancreatic secretions that facilitate absorption. Jejunoileal bypass (JIB) and the duodenal switch operation (DS) are examples of malabsorptive procedures. Profound weight loss can be achieved by a malabsorptive operation, depending upon the effective length of the functional small bowel segment. However, the benefit of superior weight loss can be offset by significant metabolic complications, such as protein calorie malnutrition and various micronutrient deficiencies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Combination of restriction and malabsorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Roux-en-Y gastric bypass (RYGB), the biliopancreatic diversion (BPD) and BPD with duodenal switch",
"    <span class=\"nowrap\">",
"     (BPD/DS)",
"    </span>",
"    are both restrictive and malabsorptive. In the RYGB, a small gastric pouch limits oral intake. However, the small bowel reconfiguration provides additional mechanisms favoring weight loss including dumping physiology and mild malabsorption.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EFFECTIVENESS OF BARIATRIC SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of surgery is to reduce the morbidity and mortality associated with obesity, and to improve metabolic and organ function. Several studies have demonstrated that bariatric surgery is effective in reducing obesity-related comorbidities, while having additional benefits such as reducing monthly medication costs and the number of sick days, and improving quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/17-27\">",
"     17-27",
"    </a>",
"    ]. A significant reduction in overall and cause-specific mortality has also been clearly demonstrated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Although there have been dramatic improvements in the safety of bariatric procedures in the past decade, bariatric surgery is not without serious risks, including significant perioperative complications and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link\">",
"     \"Complications of bariatric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Reduction of comorbidities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meta-analyses have summarized data from numerous, mainly observational studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. Findings are summarized here:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evidence supporting a benefit of bariatric surgery was strongest in patients with a BMI of &gt;40, while the benefits in those with BMI of 35 to 39 were less clear [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The mean overall percentage of excess weight lost was 61 percent, varying according to the specific bariatric procedure performed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/31\">",
"       31",
"      </a>",
"      ]. Excess weight loss refers to the difference between the preoperative BMI and a BMI of 25",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      (depending upon the study). Greater weight loss was observed with gastric bypass procedures compared with gastroplasty [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Overall mortality was less than 1 percent while adverse events occurred in approximately 20 percent of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/32\">",
"       32",
"      </a>",
"      ]. 30-day mortality was 0.1 percent for purely restrictive procedures (defined below), 0.5 percent for gastric bypass, and 1.1 percent for biliopancreatic diversion or duodenal switch [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/30,31\">",
"       30,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diabetes completely resolved in 77 percent and resolved or improved in 86 percent.",
"     </li>",
"     <li>",
"      Hyperlipidemia improved in 70 percent or more of patients.",
"     </li>",
"     <li>",
"      Hypertension resolved in 62 percent and resolved or improved in 79 percent.",
"     </li>",
"     <li>",
"      Obstructive sleep apnea resolved in 86 percent and resolved or improved in 84 percent.",
"     </li>",
"     <li>",
"      Gastroesophageal reflux symptoms improved and complete or partial regression of Barrett's esophagus has been demonstrated. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42905?source=see_link\">",
"       \"Surgical management of gastroesophageal reflux in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=see_link\">",
"       \"Management of Barrett's esophagus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urinary stress incontinence episodes decreased by 47 percent in women who achieved 8 percent weight loss [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H297382\">",
"    <span class=\"h2\">",
"     Reduction in mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reduction in comorbidities appears to translate into a 29 percent reduction in mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/17,28\">",
"     17,28",
"    </a>",
"    ]. These findings were confirmed in a large cohort study, in which nearly 8000 patients who had undergone RYGB were matched to a similar sized obese cohort [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/29\">",
"     29",
"    </a>",
"    ]. Deaths from all causes were reduced by 40 percent, from diabetes by 92 percent, from coronary disease by 56 percent, and from cancers by 60 percent.",
"   </p>",
"   <p>",
"    Although the majority of mortality data for bariatric surgery comes from patients under age 65, retrospective studies suggest that survival is improved, even in patients over age 65 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/35\">",
"     35",
"    </a>",
"    ]. However, most studies have included a primarily female population. In a retrospective study of 850 patients who were predominantly male (74 percent), bariatric surgery was not associated with improved survival in older severely obese patients after almost seven years of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Surgery compared to medical treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The striking benefits on important obesity-related morbidity contrast with relatively disappointing results in the management of severe obesity with medical and behavioral therapy. The Swedish Obese Subjects Trial (SOS) is the largest trial comparing surgical versus medical treatment of severe obesity. A total of 6328 obese (BMI &gt;34",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    for men and &gt;38",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    for women) subjects were recruited of whom 2010 underwent surgery for obesity (gastric banding, gastroplasty or gastric bypass) while 2037 chose conventional treatment. Although the study was not randomized, there was an attempt to match patients by relevant covariates. Begun in 1987, the SOS has spawned multiple publications; the following summarizes the major observations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/28,37-45\">",
"     28,37-45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight decreased by 23 percent after two years in the surgery group while it increased in the control group by 0.1 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/45\">",
"       45",
"      </a>",
"      ]. After 10 years, weight had decreased by 16 percent in the surgery group and increased in the control group by 1.6 percent. Energy intake was lower and the proportion of physically active subjects was higher in the surgery group.",
"     </li>",
"     <li>",
"      The surgery group had better 2- and 10-year incidence rates of diabetes, hypertriglyceridemia, lowered HDL levels, improved hypertension and hyperuricemia rates.",
"     </li>",
"     <li>",
"      Surgically treated patients were significantly less likely to require medications for cardiovascular disease or diabetes at two and six years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/41\">",
"       41",
"      </a>",
"      ]. Among those not already requiring such medications, surgery reduced the proportion of those who required initiation of treatment. Costs of medications were reduced significantly in the surgically treated group [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Surgically treated patients had dramatic improvement in scores on validated measures of quality of life and psychiatric dysfunction compared with only minor and sporadic improvement in medically treated patients at two years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/37,43\">",
"       37,43",
"      </a>",
"      ]. The magnitude of benefit was related mostly to the degree of weight loss, which was greater in the surgical group. After 10 years of follow-up, the improvements in quality of life diminished somewhat in the surgery group due to weight regain, but overall outcome was still significantly better in the surgical than the medically treated group [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The longer-term weight loss benefits of RYGB were confirmed by another population-based study. In a prospective study of 418 severely obese patients undergoing RYGB, 96 percent had maintained at six years more than 10 percent weight loss from baseline and 76 percent maintained more than a 20 percent weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/47\">",
"     47",
"    </a>",
"    ]. The mean weight loss at six years was 27.7 percent (95% CI 26.6-28.9 percent). In comparison, there was no significant decrease from baseline weight at six years for 417 severely obese patients who sought surgical advice but did not undergo the operation, or for 321 randomly selected severely obese individuals from the general population. In addition, diabetes remission rates at six years were significantly higher for patients undergoing a RYGB compared with the patients seeking",
"    <span class=\"nowrap\">",
"     advice/not",
"    </span>",
"    undergoing surgery and the population-based patients (62 versus 8 versus 6 percent, respectively). Patients undergoing RYGB also had better remission rates of hypertension (42 versus 18 versus 9 percent, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Treatment for type 2 diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The predominantly observational studies described above have generated much interest in the role of weight loss surgery in the treatment algorithm of diabetes, with some suggesting that bariatric surgery is one of the best treatments for type 2 diabetes. Data from randomized trials comparing surgical versus medical therapy, specifically in obese patients with diabetes, have reported a significant rate of remission of diabetes, and the cost-effectiveness of surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. In one trial, for example, 60 obese subjects (BMI between 30 and 40",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     ),",
"    </span>",
"    with type 2 diabetes diagnosed within the previous two years, were randomly assigned to conventional therapy (lifestyle modification and medical therapy) or laparoscopic adjustable banding and conventional therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/48\">",
"     48",
"    </a>",
"    ]. Remission of diabetes occurred more often in the surgical group (73 versus 13 percent). Remission was related to lower baseline A1C values and to weight loss.",
"   </p>",
"   <p>",
"    All commonly performed procedures for weight loss seem to improve glucose metabolism. The optimal surgical approach for improvement and remission of diabetes has yet to be fully elucidated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/19/28986?source=see_link\">",
"     \"Management of persistent hyperglycemia in type 2 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/19/28986?source=see_link&amp;anchor=H1665282#H1665282\">",
"     \"Management of persistent hyperglycemia in type 2 diabetes mellitus\", section on 'Surgical treatment of obesity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanism for diabetes improvement depends upon the type of surgery performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. In a meta-analysis of predominantly observational studies, diabetes resolution was highest after biliopancreatic",
"    <span class=\"nowrap\">",
"     diversion/duodenal",
"    </span>",
"    switch (95 percent) and lowest after laparoscopic adjustable gastric banding (57 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/33\">",
"     33",
"    </a>",
"    ]. One study suggested that insulin sensitivity improved in proportion to weight loss with the use of predominantly restrictive procedures, but was reversed completely by predominantly malabsorptive approaches long before normalization of body weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rapid normalization of insulin sensitivity after bypass types of bariatric procedures may be related to duodenal isolation following the bypass surgery and subsequent changes in gastrointestinal hormones (the incretins, glucagon-like peptide and glucose-dependent insulinotropic polypeptide) following surgery. In a study of eight obese women with type 2 diabetes, the release of incretins after oral glucose and their effect on insulin secretion improved within one month of Roux-en-Y gastric bypass surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/54\">",
"     54",
"    </a>",
"    ]. The role of gastrointestinal peptides in glucose homeostasis is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38298?source=see_link&amp;anchor=H3#H3\">",
"     \"Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus\", section on 'GLP-1 analogs'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21798476\">",
"    <span class=\"h2\">",
"     Liver disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obese patients are at risk for fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) which may progress to cirrhosis and hepatocellular carcinoma. NALFD can be considered part of the metabolic syndrome (insulin resistance) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/55\">",
"     55",
"    </a>",
"    ]. Insulin resistance improves after significant prolonged weight loss and may also improve immediately after bypass of the duodenum as with the RYGB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/56\">",
"     56",
"    </a>",
"    ]. Accordingly, some studies note improvement of NAFLD and metabolic syndrome with bariatric surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/55\">",
"     55",
"    </a>",
"    ]. In addition, the measurement of adipokines used to measure fatty liver disease and insulin resistance improve after weight loss surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=see_link\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While the cornerstone of therapy for NALFD and NASH is weight loss, no randomized trials of bariatric surgery for these diagnoses have been performed and the surgical approach remains controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/58\">",
"     58",
"    </a>",
"    ]. A review of 21 retrospective cohort studies showed improvement in steatosis and inflammation, with surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/58\">",
"     58",
"    </a>",
"    ]. However, four studies reviewed showed deterioration in the degree of fibrosis. In addition, none of the studies provided adequate follow up to document whether surgery had any effect on progression to cirrhosis and hepatocellular carcinoma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23882?source=see_link\">",
"     \"Natural history and management of nonalcoholic fatty liver disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Preoperative assessment may also need to be altered to help determine the best course of action in bariatric patients with liver disease as the presence of fatty liver disease does not predict poor outcome after bariatric surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cirrhosis is found incidentally during weight loss surgery in 1.4 to 3.2 percent of patients because preoperative liver function tests do not predict the extent of cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. The diagnosis of cirrhosis can be confirmed with an intraoperative biopsy. In a retrospective study of 30 patients with cirrhosis who underwent laparoscopic RYGB, there were no perioperative deaths, conversions to laparotomy, or liver-related complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/61\">",
"     61",
"    </a>",
"    ]. However, data from the Nationwide Inpatient Sample on patients who underwent bariatric surgery demonstrated lower mortality rates in patients without cirrhosis as compared with patients with compensated and decompensated cirrhosis (0.3, 0.9 and 16 percent, respectively). In addition, the average length of stay was longer for patients with decompensated and compensated cirrhosis, compared with patients without liver disease (7, 4, and 3 days, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/62\">",
"     62",
"    </a>",
"    ]. However, portal hypertension with large esophageal or gastric varices makes all bariatric procedures very risky. The safest approach when portal hypertension is detected intraoperatively is to perform a liver biopsy and conclude the procedure. The patient should then be evaluated by a hepatologist to help control the portal hypertension. Patients with mild portal hypertension may be candidates for restrictive procedures. Bariatric surgery is not recommended for patients with severe portal pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/59/17337?source=see_link\">",
"     \"Overview of the complications, prognosis, and management of cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The model for end-stage liver disease (MELD) score can be used to predict mortality in patients with cirrhosis or fatty liver disease being considered for bariatric surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/64\">",
"     64",
"    </a>",
"    ]. Those with high MELD scores should be referred to a hepatologist for evaluation. If possible, bariatric surgery for these risk patients should be performed in a high-volume tertiary referral center [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/65\">",
"     65",
"    </a>",
"    ]. The MELD score is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/25/15770?source=see_link&amp;anchor=H22#H22\">",
"     \"Model for End-stage Liver Disease (MELD)\", section on 'Assessment of surgical mortality risk in liver disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H297556\">",
"    <span class=\"h2\">",
"     Transplant patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated BMI is associated with poor outcomes after transplantation, thus the need for preoperative weight loss, surgical or nonsurgical, has been questioned.",
"   </p>",
"   <p>",
"    A retrospective study of 51,927 primary, adult renal transplants registered in the United States Renal Data System (USRDS) showed that elevated BMI was significantly associated with worse graft survival and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/66\">",
"     66",
"    </a>",
"    ]. The impact of BMI on outcomes is likely due to associated comorbid conditions and altered pharmacokinetics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The USRDS data included 188 patients who underwent bariatric surgery, 72 before being listed for transplant, 29 on the transplant waitlist, and 87 post-transplant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/68\">",
"     68",
"    </a>",
"    ]. Thirty-day mortality after bariatric surgery performed on the waitlist and post-transplant was 3.5 percent. Some centers now limit transplant to patients with a BMI &lt;35, deferring transplant evaluation until appropriate weight loss has been achieved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H297563\">",
"    <span class=\"h1\">",
"     ACCREDITATION OF BARIATRIC PROGRAMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ultimate goal of The American Society of Metabolic and Bariatric Surgeons (ASMBS) and the American College of Surgeons (ACS) is to improve patient safety and outcomes by reducing medical errors, and hence in 2012, these two organizations have combined their criteria for Bariatric Centers of Excellence into the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Project (MBS-AQIP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/69\">",
"     69",
"    </a>",
"    ]. The recommendations of the MBS-AQIP should be the standard under which hospital programs providing bariatric services should function.",
"   </p>",
"   <p>",
"    The goals of MBS-AQIP include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Accredit Metabolic and Bariatric Surgery Programs according to outcomes based standards",
"     </li>",
"     <li>",
"      Establish",
"      <span class=\"nowrap\">",
"       national/regional",
"      </span>",
"      and state collaboratives to improve care",
"     </li>",
"     <li>",
"      Decrease morbidity by 50 percent throughout five years",
"     </li>",
"     <li>",
"      Decrease readmissions, reoperations",
"     </li>",
"     <li>",
"      Improve the value of metabolic surgery by increasing safety, improving efficacy and decreasing cost of care",
"     </li>",
"     <li>",
"      Share best practices",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The benefits of these guidelines include the improved ability to compare short-term and long-term results across institutions providing medical and surgical bariatric services. For those hospitals that do provide bariatric care, the recommendations of the MBS-AQIP should be the standard under which they operate. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for the surgical management of severe obesity were first outlined by the National Institutes of Health (NIH) Consensus Development Panel in 1991 (",
"    <a class=\"graphic graphic_table graphicRef60096 \" href=\"mobipreview.htm?1/25/1435\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/70\">",
"     70",
"    </a>",
"    ]. Potentially eligible patients should:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Be well-informed and motivated",
"     </li>",
"     <li>",
"      Have a BMI &gt;40",
"     </li>",
"     <li>",
"      Have acceptable risk for surgery",
"     </li>",
"     <li>",
"      Have failed previous nonsurgical weight loss",
"     </li>",
"     <li>",
"      Adults with a BMI &gt;35 who have serious comorbidities such as diabetes, sleep apnea, obesity-related cardiomyopathy, or severe joint disease may also be candidates",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bariatric surgery should be performed in conjunction with a comprehensive follow-up plan consisting of nutritional, behavioral, and medical programs. Clinical practice guidelines from the American College of Physicians for management of obesity in primary care are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/45/13016?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of therapy for obesity in adults\", section on 'Clinical guidelines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraindications to bariatric surgery include patients with untreated major depression or psychosis, binge-eating disorders, current drug and alcohol abuse, severe cardiac disease with prohibitive anesthetic risks, severe coagulopathy, or inability to comply with nutritional requirements including life-long vitamin replacement. Bariatric surgery in advanced (above 65) or very young age (under 18) is controversial, but is considered when comorbidity is severe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CHOOSING A PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly performed bariatric surgery procedures are laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y gastric bypass (RYGB). There are benefits and risks associated with each procedure.",
"   </p>",
"   <p>",
"    The comparative efficacy and safety of the procedures were evaluated in a five-year trial of 50 obese patients (mean BMI 43",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    randomly assigned to LAGB versus laparoscopic RYGB (LRYGB) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/72\">",
"     72",
"    </a>",
"    ]. After five years, patients in the LRYGB group lost a greater percentage of excess body weight (67 versus 47 percent) and had a lower failure rate (4 versus 35 percent). A similar study of 250 patients randomly assigned to gastric bypass or gastric banding showed that LRYGB resulted in better weight loss, but was associated with more complications and a higher 30-day readmission rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis of 14 studies (13 observational and one randomized trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/72\">",
"     72",
"    </a>",
"    ]) evaluating clinical outcomes after LAGB and RYGB showed the following advantages and disadvantages of RYGB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/74\">",
"     74",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight loss at one year was superior (median difference 26 percent, 95% CI 19-34 percent)",
"     </li>",
"     <li>",
"      Resolution of comorbidities, such as diabetes and dyslipidemia, was better",
"     </li>",
"     <li>",
"      Operative times and length of hospitalization were longer (median differences of 68 minutes and two days, respectively)",
"     </li>",
"     <li>",
"      Perioperative complications (9 versus 5 percent) were greater, but reoperation rates (16 versus 24 percent) lower",
"     </li>",
"     <li>",
"      Mortality was higher, although it was low in both groups (0.06 and 0.17 percent for LAGB and RYGB, respectively)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, in this meta-analysis of predominantly observational studies, RYGB was associated with greater long-term success but higher short-term morbidity.",
"   </p>",
"   <p>",
"    In addition to laparoscopic Roux-en-Y gastric bypass and adjustable gastric band, biliopancreatic diversion with duodenal switch, and primary laparoscopic sleeve gastrectomy are also effective means of treating severe obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/52,75,76\">",
"     52,75,76",
"    </a>",
"    ]. In the United States, two national databases, Bariatric Outcomes Longitudinal Database&trade; (BOLD) and National Surgical Quality Improvement Program (NSQIP) are being implemented to track weight loss surgery outcomes. Results from these prospective, risk-adjusted and benchmarked data collection systems will hopefully provide useful data for further comparison of procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The choice of procedure depends upon patient preference, the institution, and expertise of the surgeons. The surgeons, and all members of the multidisciplinary bariatric team, should educate patients fully regarding the risks, benefits and alternatives to weight loss surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/79\">",
"     79",
"    </a>",
"    ]. Data from the National Inpatient Sample database on 304,515 patients showed that male gender (odds ratio 1.7), age &gt;50 years (odds ratio 3.8), congestive heart failure (odds ratio&nbsp;9.5), peripheral vascular disease (odds ratio 7.4), chronic renal failure (odds ratio 2.7), and open surgery (odds ratio 5.5), were associated with greater mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/80\">",
"     80",
"    </a>",
"    ]. Ethnicity, hypertension, diabetes, liver disease, chronic lung disease, sleep apnea, and alcohol abuse, had no significant association with mortality. These factors should be considered when counseling patients preoperatively.",
"   </p>",
"   <p>",
"    A thorough discussion of the pros and cons of the various surgical approaches as part of the informed consent is very important. Patients need to understand the need to make major dietary and lifestyle changes postoperatively, and must have realistic expectations. The medical management of patients after bariatric surgery is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26362?source=see_link\">",
"     \"Medical management of patients after bariatric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many accredited multidisciplinary programs hold information sessions to discuss different weight loss surgery options and provide extensive nutritional education. Patients planning surgery are usually tested on their understanding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/81\">",
"     81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/5/33876?source=see_link\">",
"     \"Patient information: Weight loss treatments (Beyond the Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/37/9811?source=see_link\">",
"     \"Patient information: Weight loss surgery (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     BARIATRIC SURGICAL PROCEDURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Roux-en-Y gastric bypass",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Roux-en-Y gastric bypass (RYGB) was developed in the 1960s based on the observation that patients who underwent partial gastrectomy experienced significant long-term weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/82\">",
"     82",
"    </a>",
"    ]. Many subsequent modifications have been made to improve the weight loss outcome and limit operative complications. It is the most common bariatric procedure performed in the United States and is considered the gold standard among bariatric procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Surgical procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Roux-en-Y gastric bypass configuration is characterized by a small (less than 30 mL) proximal gastric pouch divided and separated from the stomach remnant, with drainage of food to the rest of the gastrointestinal tract via a small gastrojejunal anastomosis and a Roux-en-Y small bowel arrangement (",
"    <a class=\"graphic graphic_figure graphicRef70745 \" href=\"mobipreview.htm?5/15/5364\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef79256 \" href=\"mobipreview.htm?32/35/33329\">",
"     figure 2",
"    </a>",
"    ). The small pouch and the small outlet act to restrict caloric intake, as seen in VBG and LAGB. A much larger gastric remnant becomes disconnected from the food stream while secretion of gastric acid, pepsin, and intrinsic factor continues.",
"   </p>",
"   <p>",
"    The small intestine is then divided at a distance of 30 to 50 cm distal to the Ligament of Treitz. By dividing the bowel, the surgeon creates a proximal biliopancreatic limb that transports the secretions from the gastric remnant, liver, and pancreas. The Roux limb (or alimentary limb) is anastomosed to the new gastric pouch, and functions to drain consumed food. The cut ends of the biliopancreatic limb and the Roux limb are then connected 75 to 150 cm distally from the gastrojejunostomy. Major digestion and absorption of nutrients then occurs in the common channel where pancreatic enzymes and bile mix with ingested food.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Minimally invasive technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most bariatric procedures are now performed laparoscopically. Data from the Nationwide Inpatient Sample from 2003 through 2008 documented that the proportion of laparoscopic bariatric operations increased from 20 percent in 2003 to 90 percent in 2008 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/9\">",
"     9",
"    </a>",
"    ]",
"    <strong>",
"     .",
"    </strong>",
"    Minimally invasive techniques were first applied in bariatric surgery in the 1990s. The first laparoscopic RYGB series was reported in 1994 in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/83\">",
"     83",
"    </a>",
"    ]. Although technically challenging with a steep learning curve, laparoscopic RYGB can be performed safely by experienced surgeons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/75,84\">",
"     75,84",
"    </a>",
"    ]. The laparoscopic approach offers several advantages, such as reduced blood loss, lower incidence of incisional hernia, wound infection, faster recovery, and a shorter hospital stay than with open surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/85-87\">",
"     85-87",
"    </a>",
"    ]. Although the procedure can be limited by patient size, instrument and trocar length, even the extremely large patients have been successfully completed laparoscopically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Weight loss mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the RYGB, with its small pouch, is primarily a restrictive operation, a malabsorptive component also contributes to weight loss. RYGB has been shown repeatedly to be better than purely restrictive procedures, such as the vertical banded gastroplasty (VBG), in long-term weight reduction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/89\">",
"     89",
"    </a>",
"    ]. Other mechanisms, such as dumping syndrome, Roux limb length, and gut hormones, may have a role in the weight loss seen following gastric bypass:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastrojejunostomy anatomy (connection between the stomach pouch and jejunum) is associated with dumping physiology, and causes unpleasant symptoms of lightheadedness, nausea, diaphoresis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      abdominal pain, and diarrhea when a high sugar meal is ingested [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/90\">",
"       90",
"      </a>",
"      ]. This response may serve as a negative conditioning response against consumption of a high sugar diet postoperatively.",
"     </li>",
"     <li>",
"      The optimal length of the Roux limb in achieving the best balance between weight reduction and complications of malabsorption is controversial. Increasing Roux limb length can lead to increased malabsorption, since lengthening the Roux limb effectively shortens the common limb where major digestion and absorption of the ingested nutrients occur. At present, most surgeons do not make the Roux length longer than 150 cm. Distal gastric bypass with a short common limb has been used to treat patients with inadequate weight loss following standard RYGB, but the risk for metabolic complications increases similar to other malabsorptive operations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/91\">",
"       91",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ghrelin is a peptide hormone secreted in the foregut (stomach and duodenum) that stimulates the early phase of meal consumption. The normal pulsatile release of this orexigenic (appetite-producing) hormone appears to be inhibited in gastric bypass patients due to its unique foregut bypass configuration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. Such inhibition of ghrelin has also been observed in laparoscopic sleeve gastrectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/13\">",
"       13",
"      </a>",
"      ]. The reduced ghrelin levels may contribute to the characteristic loss of appetite seen in post RYGB patients. An exaggerated response of peptide YY (PYY) may also contribute to the loss of appetite [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/38/13929?source=see_link\">",
"       \"Pathogenesis of obesity\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16758?source=see_link\">",
"       \"Ghrelin\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excess weight loss (EWL) after Roux-en-Y gastric bypass (RYGB) is durable and reliable. On average, 62 to 68 percent EWL is reported after the first year. Early weight loss following gastric bypass is typically rapid, but usually reaches a plateau after one to two years to an average EWL percent between 50 to 75 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/85,86,92,93\">",
"     85,86,92,93",
"    </a>",
"    ]. Sustained weight loss is seen up to 16 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/92\">",
"     92",
"    </a>",
"    ], which makes this procedure an excellent tool for a permanent surgical weight loss. Improvement",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    resolution of comorbid conditions (including diabetes, sleep apnea, hypertension, and dyslipidemia) following gastric bypass has also been well established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/85,92-95\">",
"     85,92-95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some patients may experience a precipitous drop in blood glucose due to altered insulin metabolism after RYGB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/96,97\">",
"     96,97",
"    </a>",
"    ]. Clinical approaches to severe hypoglycemia after gastric bypass are addressed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link&amp;anchor=H37#H37\">",
"     \"Complications of bariatric surgery\", section on 'Postoperative hypoglycemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Laparoscopic adjustable gastric banding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laparoscopic gastric banding (LAGB) is a purely restrictive procedure that compartmentalizes the upper stomach by placing a tight, adjustable prosthetic band around the entrance to the stomach (",
"    <a class=\"graphic graphic_figure graphicRef60081 \" href=\"mobipreview.htm?21/54/22368\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although LAGB was performed extensively in Europe and Australia for almost a decade, it was not until June 2001 that the first adjustable band (LapBand, Allergan) was approved for use in the United States. Another adjustable gastric band also received FDA approval (Realize band, Ethicon) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/98\">",
"     98",
"    </a>",
"    ]. It works on similar principle, and has similar short-term outcomes to LapBand. In 2011, the FDA approved the laparoscopic adjustable gastric band for use in patients with BMI greater than 30 with one or more weight related comorbid conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/99\">",
"     99",
"    </a>",
"    ]. Use of the gastric band for this population has not been universally embraced by the bariatric surgery community or the third party insurance payers because of the high complication rate. &nbsp;",
"   </p>",
"   <p>",
"    The gastric band consists of a soft, locking silicone ring connected to an infusion port placed in the subcutaneous tissue. The port may be accessed with relative ease by a syringe and needle. Injection of saline into the port leads to reduction in the band diameter, resulting in an increased degree of restriction. The band is adjustable and is placed laparoscopically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/100,101\">",
"     100,101",
"    </a>",
"    ]. Postoperatively, the patient must be followed with frequent office visits to the nutritionist for diet counseling and surgical staff for band adjustments (",
"    <a class=\"graphic graphic_figure graphicRef67530 \" href=\"mobipreview.htm?38/37/39519\">",
"     figure 4",
"    </a>",
"    ). The goal of band adjustments is to give the patient restriction of about a cup of dried food and satiety for at least 1.5 to 2 hrs after a meal.",
"   </p>",
"   <p>",
"    Indications for the use of LAGB are similar to the indications for gastric bypass, and patients must meet full NIH criteria (",
"    <a class=\"graphic graphic_table graphicRef60096 \" href=\"mobipreview.htm?1/25/1435\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/70\">",
"     70",
"    </a>",
"    ]. LAGB is generally contraindicated in patients with portal hypertension, connective tissue disorders with severe esophageal dysmotility, or chronic steroid use (relative contraindication).",
"   </p>",
"   <p>",
"    LAGB has gained significant attention among bariatric surgeons and patients primarily because of its perceived simplicity and lower perioperative complication rates when compared with more involved procedures such as RYGB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/102\">",
"     102",
"    </a>",
"    ]. Because of its many advantages, it has largely replaced the conventional VBG as the main restrictive procedure for treatment of severe obesity:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      LAGB does not require division of the stomach or intestinal resection. As a result, it has the lowest mortality rate (0 to 0.5 percent) among all bariatric procedures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/103,104\">",
"       103,104",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The band eliminates the need for staple lines used in VBG that may break down and cause weight regain.",
"     </li>",
"     <li>",
"      Avoidance of a fixed prosthetic mesh at the stoma reduces the incidence of stomal stenosis seen in VBG.",
"     </li>",
"     <li>",
"      The adjustability of the outlet by the new band design offers a theoretical advantage of addressing various nutritional issues after surgery. As an example, a patient who becomes pregnant following this procedure may have her stoma widened to allow for greater caloric and fluid intake, if necessary. In addition, restoration of the original anatomy by the removal of the band is possible. A significant scar capsule remains after band removal, however, which may contribute to the increased rate of complications seen with revisional bariatric procedures following failed banding procedures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/105\">",
"       105",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The effectiveness of the LAGB for achieving excess weight loss has been variable. As a general rule, weight loss following LAGB is more gradual and less, compared with gastric bypass procedures, but some have reported comparable long-term outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/103\">",
"     103",
"    </a>",
"    ]. Based on a few retrospective studies, there was a 15 to 20 percent EWL at three months, 40 to 53 percent EWL at one year, with eventual increases in up to 45 to 75 percent EWL at two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/106-109\">",
"     106-109",
"    </a>",
"    ]. A retrospective review of 3227 obese patients undergoing LAGB identified a durable weight loss of 47 percent EWL at 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/110\">",
"     110",
"    </a>",
"    ]. In addition to weight loss, LAGB is associated with improvements in various comorbidities (diabetes, asthma, sleep apnea, hypertension) and quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/20,21,103,111-114\">",
"     20,21,103,111-114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications of LAGB are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link&amp;anchor=H40#H40\">",
"     \"Complications of bariatric surgery\", section on 'Gastric banding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Sleeve gastrectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleeve gastrectomy (SG) is a partial gastrectomy, in which the majority of the greater curvature of the stomach is removed and a tubular stomach is created. SG was initially offered to patients with super severe obesity (BMI &gt;",
"    <span class=\"nowrap\">",
"     60kg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    as the first stage in surgical management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/115,116\">",
"     115,116",
"    </a>",
"    ]. The tubular stomach is small in its capacity (restriction), resistant to stretching due to the absence of the fundus, and has few ghrelin-producing cells (a gut hormone involved in regulating food intake) (",
"    <a class=\"graphic graphic_figure graphicRef54612 \" href=\"mobipreview.htm?35/40/36480\">",
"     figure 5",
"    </a>",
"    ). Although SG is a restrictive procedure, gastric motility changes also occur with surgery and may affect weight loss outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/117,118\">",
"     117,118",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/38/13929?source=see_link\">",
"     \"Pathogenesis of obesity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16758?source=see_link\">",
"     \"Ghrelin\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    SG is technically easier than RYGB, as it does not require multiple anastomoses. It is also safer, as it reduces the risks of internal herniation and protein and mineral malabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/119,120\">",
"     119,120",
"    </a>",
"    ]. SG can be considered a restrictive option for the treatment of severe obesity as a single stage primary operation, rather than just a bridge procedure to a more technically challenging gastric bypass or biliopancreatic diversion in high-risk patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/116,121\">",
"     116,121",
"    </a>",
"    ]. A randomized study of 80 patients showed that SG results in better weight loss and hunger control at three years after surgery than adjustable gastric banding (EWL of 66 versus 48 percent respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/122\">",
"     122",
"    </a>",
"    ]. The benefits of SG have been attributed in part to better suppression of ghrelin compared with gastric bypass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SG is an effective and relatively safe procedure that appears to combine the safety profile of the gastric band with the effectiveness of the more complicated procedures, such as the gastric bypass. Data from the American College of Surgeons-Bariatric Surgery accreditation program on 944 SG, 12,193 gastric banding, and 15,479 RYGB patients showed no difference in mortality between procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/123\">",
"     123",
"    </a>",
"    ]. SG had higher morbidity, readmission and reoperation rates than the gastric band, but less than the RYGB with one year follow up. Weight loss after SG also lies between that of the gastric band and the RYGB. Similar results were reported in other series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/124,125\">",
"     124,125",
"    </a>",
"    ]. One retrospective review of 176 patients shows that persistent reflux occurred in 47 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/126\">",
"     126",
"    </a>",
"    ]. However, long term data are still lacking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/121\">",
"     121",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Biliopancreatic diversion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The biliopancreatic diversion (BPD) was introduced as a solution to the high rates of liver failure resulting from bowel exclusion in the jejunoileal bypass (",
"    <a class=\"graphic graphic_figure graphicRef67432 \" href=\"mobipreview.htm?18/53/19284\">",
"     figure 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/127\">",
"     127",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Jejunoileal bypass'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The procedure consists of a partial gastrectomy and gastroileostomy with a long segment of Roux limb and a short common channel (the part of the small bowel that receives both food and biliopancreatic secretions) resulting in fat and starch malabsorption. Up to 72 percent excess weight loss at 18 years after surgery has been reported. Laparoscopic BPD has also been performed with acceptable outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/128\">",
"     128",
"    </a>",
"    ]. Its use has been limited by the high rates of protein malnutrition, anemia, diarrhea, and stomal ulceration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/129\">",
"     129",
"    </a>",
"    ]. In the United States, the role of BPD has generally been limited to revisional bariatric surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H772598659\">",
"    <span class=\"h2\">",
"     Duodenal switch",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duodenal switch (DS) procedure combines gastric restriction (sleeve gastrectomy or vertical gastrectomy) and malabsorption (DS with functional shortening of the small intestine) to attain weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/130\">",
"     130",
"    </a>",
"    ]. The DS with shortening of the small intestine is achieved with division of the duodenum 4 cm distal to the pylorus, anastomosis of the duodenum to the distal ileum, and anastomosis of the biliopancreatic limb to the distal ileum to create a 100 cm common channel and a 150 cm enteric limb. A randomized trial of 60 patients who underwent either gastric bypass or DS showed greater weight loss with the duodenal switch procedure than the gastric bypass (25 versus 17 kg respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/131\">",
"     131",
"    </a>",
"    ]. However, patients who underwent the DS had a much higher rate of adverse events as compared with the gastric bypass (62 vs 32 percent of patients respectively). In the DS group, there were 3 cases of protein calorie malnutrition, 2 cases of night blindness and 1 case of severe iron deficiency. The DS patients also had lower levels of vitamin A and D. Thus, the DS procedure cannot be recommended for surgical management of obesity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Biliopancreatic diversion with duodenal switch",
"    </span>",
"    &nbsp;&mdash;&nbsp;The biliopancreatic diversion with duodenal switch",
"    <span class=\"nowrap\">",
"     (BPD/DS)",
"    </span>",
"    is a variant of the BPD and is primarily a malabsorptive operation (",
"    <a class=\"graphic graphic_figure graphicRef54159 \" href=\"mobipreview.htm?19/33/19987\">",
"     figure 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/132\">",
"     132",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     BPD/DS",
"    </span>",
"    procedure involves a partial sleeve gastrectomy with preservation of the pylorus, and creation of a Roux limb with a short common channel. The",
"    <span class=\"nowrap\">",
"     BPD/DS",
"    </span>",
"    procedure differs from the BPD in the portion of the stomach that is removed, as well as preservation of the pylorus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/129,132\">",
"     129,132",
"    </a>",
"    ]. It is associated with a lower incidence of stomal ulceration and diarrhea than with BPD alone. Although complex,",
"    <span class=\"nowrap\">",
"     BPD/DS",
"    </span>",
"    has been performed laparoscopically by several groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/133,134\">",
"     133,134",
"    </a>",
"    ]. This procedure is performed at only a few centers in the United States.",
"   </p>",
"   <p>",
"    This procedure has been advocated for patients with very severe obesity (BMI &gt;50",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     ),",
"    </span>",
"    a group in which it has been associated with improved weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/52,76\">",
"     52,76",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     BPD/DS",
"    </span>",
"    is not widely accepted as a first-line surgical treatment for less severe obesity because of concerns regarding the risks of long-term malabsorption.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Intragastric balloon",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intragastric balloon (Bioenterics Intragastric Balloon, Allergan) is a temporary alternative for weight loss in moderately obese individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/135-138\">",
"     135-138",
"    </a>",
"    ]. It consists of a soft, saline-filled balloon, placed endoscopically, which promotes a feeling of satiety and restriction (",
"    <a class=\"graphic graphic_figure graphicRef58305 \" href=\"mobipreview.htm?42/27/43455\">",
"     figure 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The intragastric balloon is not available for use in the United States, outside of clinical trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/139\">",
"     139",
"    </a>",
"    ]. Mean excess weight loss is reported to be 38 percent and 48 percent for 500 and 600 mL balloons, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/136\">",
"     136",
"    </a>",
"    ]. However, the results of a Brazilian multicenter study indicate weight loss is transient, with only 26 percent of patients maintaining over 90 percent of the excess weight loss out over one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/137\">",
"     137",
"    </a>",
"    ]. It appears to reduce the risk of conversion to open surgery and the risk of intraoperative complications when it is used for preoperative weight loss in super-obese patients before a definitive bariatric procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/138\">",
"     138",
"    </a>",
"    ]. Side effects include nausea, vomiting, abdominal pain, ulceration, and balloon migration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Vertical banded gastroplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertical banded gastroplasty (VBG) is a purely restrictive procedure in which the upper part of the stomach is partitioned by a vertical staple line with a tight outlet wrapped by a prosthetic mesh or band (",
"    <a class=\"graphic graphic_figure graphicRef57137 \" href=\"mobipreview.htm?35/28/36303\">",
"     figure 9",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The small upper stomach pouch is filled quickly by solid food, and prevents consumption of a large meal. Weight loss occurs because of decreased caloric intake of solid food. Patients who have undergone VBG can be expected to have excess weight loss (EWL) of 58 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/140\">",
"     140",
"    </a>",
"    ]. The effectiveness of such a restrictive mechanism depends upon the durability of pouch and stoma (outlet) size.",
"   </p>",
"   <p>",
"    Ingestion of high-calorie liquid meals and gradually increased pouch capacity due to overeating has been some of the major causes of its failure. Sweets eaters who rely on soft meals (ie, ice cream, milk shakes) do not benefit significantly from this procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    VBG has been replaced largely by other procedures and is rarely performed due to lack of",
"    <span class=\"nowrap\">",
"     sustained/desired",
"    </span>",
"    weight loss, as well as the high incidence of complications requiring revision (20 to 56 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/89,141-145\">",
"     89,141-145",
"    </a>",
"    ]. The majority of revisions are required for staple line disruption, stomal stenosis, band erosion, band disruption, pouch dilatation, vomiting, and gastroesophageal reflux disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link\">",
"     \"Complications of bariatric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Endoluminal vertical gastroplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic methods for suturing the stomach have been developed, which offer the potential to perform gastric-restrictive procedures endoluminally. Initial experience is promising, but longer-term studies are needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/146\">",
"     146",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Jejunoileal bypass",
"    </span>",
"    &nbsp;&mdash;&nbsp;The jejunoileal bypass was one of the first bariatric operations, performed initially in 1969 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/147\">",
"     147",
"    </a>",
"    ]. It has since been abandoned due to the high complication rate and frequent need for revisional surgery. Its importance lies in the care of surviving patients who have undergone this procedure.",
"   </p>",
"   <p>",
"    The procedure was performed by dividing the jejunum close to the ligament of Treitz, and connecting it a short distance proximal to the ileocecal valve (",
"    <a class=\"graphic graphic_figure graphicRef53171 \" href=\"mobipreview.htm?23/34/24098\">",
"     figure 10",
"    </a>",
"    ), thereby diverting a long segment of small bowel, resulting in malabsorption. Although excess weight loss was excellent, jejunoileal bypass was associated with multiple complications, such as liver failure (up to 30 percent), death, diarrhea, electrolyte imbalances, oxalate renal stones, vitamin deficiencies, malnutrition, and arthritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/148-152\">",
"     148-152",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who have undergone this procedure should be monitored closely for complications (particularly liver disease) and undergo reversal if such complications arise. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link\">",
"     \"Complications of bariatric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Liposuction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not generally considered to be a bariatric procedure, removal of fat by aspiration after injection of physiologic saline has been used to remove and contour subcutaneous fat. While this can result in reduction in fat mass and weight, the amount of weight loss is insignificant in comparison with bariatric procedures, and it does not appear to improve insulin sensitivity or risk factors for coronary heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/153\">",
"     153",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/45/13016?source=see_link&amp;anchor=H24#H24\">",
"     \"Overview of therapy for obesity in adults\", section on 'Liposuction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bariatric surgery has serious risks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/31/33274/abstract/78\">",
"     78",
"    </a>",
"    ]. Complications of these procedures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link\">",
"     \"Complications of bariatric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/31/14835?source=see_link\">",
"       \"Patient information: Weight loss surgery (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/5/33876?source=see_link\">",
"       \"Patient information: Weight loss treatments (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/37/9811?source=see_link\">",
"       \"Patient information: Weight loss surgery (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obesity is a major health problem, and its incidence is increasing rapidly in developed countries. Severe obesity leads to numerous medical problems and a shortened life expectancy. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Body mass index (BMI) is the most practical measure of a person's adiposity (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?39/41/40593?source=see_link\">",
"       calculator 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Body mass index'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bariatric surgical approaches are based primarily on two main mechanisms: restriction of caloric intake via a small stomach reservoir and malabsorption of nutrients via reduced functional small bowel length. Restrictive procedures are generally simpler in techniques, but seem to achieve less weight loss. Malabsorptive procedures are highly effective in weight loss, but can carry significant metabolic complications. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Mechanism of weight loss'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bariatric surgery is effective in reducing obesity-related comorbidities and mortality. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Effectiveness of bariatric surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bariatric surgery needs to be performed in conjunction with a comprehensive follow-up plan consisting of nutritional, behavioral, and medical programs. These complex procedures must be performed in appropriately accredited facilities and follow the combined guidelines of the American College of Surgeons and the American Society of Metabolic and Bariatric Surgeons (MBS-AQIP). (See",
"      <a class=\"local\" href=\"#H297563\">",
"       'Accreditation of bariatric programs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Roux-en-Y gastric bypass has been the most commonly performed procedure in the United States due to its multiple mechanisms of action and durable long-term weight loss. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Roux-en-Y gastric bypass'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laparoscopic Roux-en-Y gastric bypass, compared to the open approach, can decrease surgical pain, infectious and hernia complications, as well as allow for quicker postoperative recovery. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Roux-en-Y gastric bypass'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laparoscopic adjustable gastric banding is becoming increasingly more popular in the United States due to its simplicity in technique, adjustability, reversibility, and relatively low perioperative mortality. Weight loss following gastric banding is more gradual and less, compared with gastric bypass procedures. Frequent band adjustments and revisional surgery may be required over time. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Laparoscopic adjustable gastric banding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laparoscopic vertical sleeve gastrectomy is an effective procedure to treat severe obesity. This procedure combines the nutritional benefits of a purely restrictive procedure, such as the adjustable gastric band, and the weight loss benefits of the gastric bypass. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Sleeve gastrectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laparoscopic biliopancreatic diversion with duodenal switch",
"      <span class=\"nowrap\">",
"       (BPD/DS)",
"      </span>",
"      is an effective operation for very severe obesity (BMI &gt;50.0",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"       ).",
"      </span>",
"      <span class=\"nowrap\">",
"       BPD/DS",
"      </span>",
"      is not widely accepted as a first-line surgical treatment in less severely obese patients because of concerns regarding the long-term risks of nutritional deficiencies. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Biliopancreatic diversion with duodenal switch'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. www.cdc.gov/obesity/data/trends.html (Accessed on January 28, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/2\">",
"      Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/3\">",
"      Vlad I. Obesity costs UK economy 2bn pounds sterling a year. BMJ 2003; 327:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/4\">",
"      Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/5\">",
"      Balsiger BM, Murr MM, Poggio JL, Sarr MG. Bariatric surgery. Surgery for weight control in patients with morbid obesity. Med Clin North Am 2000; 84:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/6\">",
"      Ludwig DS, Pollack HA. Obesity and the economy: from crisis to opportunity. JAMA 2009; 301:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/7\">",
"      Frezza EE, Wachtel MS, Ewing BT. The impact of morbid obesity on the state economy: an initial evaluation. Surg Obes Relat Dis 2006; 2:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/8\">",
"      Singh RB, Pella D, Mechirova V, et al. Prevalence of obesity, physical inactivity and undernutrition, a triple burden of diseases during transition in a developing economy. The Five City Study Group. Acta Cardiol 2007; 62:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/9\">",
"      Nguyen NT, Masoomi H, Magno CP, et al. Trends in use of bariatric surgery, 2003-2008. J Am Coll Surg 2011; 213:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/10\">",
"      Tritos NA, Mun E, Bertkau A, et al. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 2003; 11:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/11\">",
"      Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/12\">",
"      Korner J, Bessler M, Cirilo LJ, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005; 90:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/13\">",
"      Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/14\">",
"      le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/15\">",
"      Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/16\">",
"      Roth CL, Reinehr T, Schernthaner GH, et al. Ghrelin and obestatin levels in severely obese women before and after weight loss after Roux-en-Y gastric bypass surgery. Obes Surg 2009; 19:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/17\">",
"      Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/18\">",
"      Abu-Abeid S, Keidar A, Szold A. Resolution of chronic medical conditions after laparoscopic adjustable silicone gastric banding for the treatment of morbid obesity in the elderly. Surg Endosc 2001; 15:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/19\">",
"      Ballantyne GH. Measuring outcomes following bariatric surgery: weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction. Obes Surg 2003; 13:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/20\">",
"      Dixon JB, Dixon ME, O'Brien PE. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res 2001; 9:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/21\">",
"      Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002; 184:51S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/22\">",
"      Monk JS Jr, Dia Nagib N, Stehr W. Pharmaceutical savings after gastric bypass surgery. Obes Surg 2004; 14:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/23\">",
"      Monteforte MJ, Turkelson CM. Bariatric surgery for morbid obesity. Obes Surg 2000; 10:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/24\">",
"      Sj&ouml;str&ouml;m CD, Peltonen M, Wedel H, Sj&ouml;str&ouml;m L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000; 36:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/25\">",
"      Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003; 289:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/26\">",
"      Greenway SE, Greenway FL 3rd, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 2002; 137:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/27\">",
"      Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/28\">",
"      Sj&ouml;str&ouml;m L, Narbro K, Sj&ouml;str&ouml;m CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/29\">",
"      Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/30\">",
"      Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/31\">",
"      Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292:1724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/32\">",
"      Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/33\">",
"      Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/34\">",
"      Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009; 360:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/35\">",
"      Perry CD, Hutter MM, Smith DB, et al. Survival and changes in comorbidities after bariatric surgery. Ann Surg 2008; 247:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/36\">",
"      Maciejewski ML, Livingston EH, Smith VA, et al. Survival among high-risk patients after bariatric surgery. JAMA 2011; 305:2419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/37\">",
"      Karlsson J, Sj&ouml;str&ouml;m L, Sullivan M. Swedish obese subjects (SOS)--an intervention study of obesity. Two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord 1998; 22:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/38\">",
"      Torgerson JS, Sj&ouml;str&ouml;m L. The Swedish Obese Subjects (SOS) study--rationale and results. Int J Obes Relat Metab Disord 2001; 25 Suppl 1:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/39\">",
"      Sj&ouml;str&ouml;m L, Larsson B, Backman L, et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 1992; 16:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/40\">",
"      Torgerson JS. [The \"Swedish Obese Subjects\" (SOS) Study. What does weight loss really accomplish?]. MMW Fortschr Med 2002; 144:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/41\">",
"      Agren G, Narbro K, N&auml;slund I, et al. Long-term effects of weight loss on pharmaceutical costs in obese subjects. A report from the SOS intervention study. Int J Obes Relat Metab Disord 2002; 26:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/42\">",
"      Narbro K, Agren G, Jonsson E, et al. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002; 162:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/43\">",
"      Ryd&eacute;n A, Sullivan M, Torgerson JS, et al. A comparative controlled study of personality in severe obesity: a 2-y follow-up after intervention. Int J Obes Relat Metab Disord 2004; 28:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/44\">",
"      Sj&ouml;str&ouml;m CD, Lissner L, Wedel H, Sj&ouml;str&ouml;m L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/45\">",
"      Sj&ouml;str&ouml;m L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351:2683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/46\">",
"      Karlsson J, Taft C, Ryd&eacute;n A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond) 2007; 31:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/47\">",
"      Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA 2012; 308:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/48\">",
"      Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/49\">",
"      Peterli R, W&ouml;lnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009; 250:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/50\">",
"      Keating CL, Dixon JB, Moodie ML, et al. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care 2009; 32:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/51\">",
"      Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 2009; 150:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/52\">",
"      Prachand VN, Ward M, Alverdy JC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI &gt; or = 50 kg/m2) compared with gastric bypass. J Gastrointest Surg 2010; 14:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/53\">",
"      Muscelli E, Mingrone G, Camastra S, et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 2005; 118:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/54\">",
"      Laferr&egrave;re B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/55\">",
"      Mattar SG, Velcu LM, Rabinovitz M, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 2005; 242:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/56\">",
"      Reed MA, Pories WJ, Chapman W, et al. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. J Clin Endocrinol Metab 2011; 96:2525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/57\">",
"      Sell H, Divoux A, Poitou C, et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2010; 95:2892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/58\">",
"      Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev 2010; :CD007340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/59\">",
"      Ribeireiro T, Swain J, Sarr M, et al. NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis. Obes Surg 2011; 21:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/60\">",
"      Brolin RE, Bradley LJ, Taliwal RV. Unsuspected cirrhosis discovered during elective obesity operations. Arch Surg 1998; 133:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/61\">",
"      Dallal RM, Mattar SG, Lord JL, et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg 2004; 14:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/62\">",
"      Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9:897.",
"     </a>",
"    </li>",
"    <li>",
"     Barreto JC, Sarr MG, Swain JM. Bariatric surgery in patients with liver cirrhosis and portal hypertension. Bariatric Times 2009. bariatrictimes.com/2009/07/14/bariatric-surgery-in-patients-with-liver-cirrhosis-and-portal-hypertension/ (Accessed on August 19, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/64\">",
"      Northup PG, Wanamaker RC, Lee VD, et al. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 2005; 242:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/65\">",
"      Varela JE, Hinojosa MW, Nguyen NT. Bariatric surgery outcomes in morbidly obese with the metabolic syndrome at US academic centers. Obes Surg 2008; 18:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/66\">",
"      Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002; 73:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/67\">",
"      Killackey M, Zhang R, Sparks K, et al. Challenges of abdominal organ transplant in obesity. South Med J 2010; 103:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/68\">",
"      Modanlou KA, Muthyala U, Xiao H, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation 2009; 87:1167.",
"     </a>",
"    </li>",
"    <li>",
"     Blackstone R. Overview of the transition of the ASMBS BSCOE to the MBS AQIP. 29th annual meeting American Society for Metabolic &amp; Bariatric Surgery, June 2012. file://s3.amazonaws.com/publicASMBS/Items_of_Interest/Overview_of_the_Transition_of_the_ASMBS_BSCOE_Revised_for_Sunday_Presentation_June_17.pdf (Accessed on September 04, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/70\">",
"      NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991; 115:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/71\">",
"      Yermilov I, McGory ML, Shekelle PW, et al. Appropriateness criteria for bariatric surgery: beyond the NIH guidelines. Obesity (Silver Spring) 2009; 17:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/72\">",
"      Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 2007; 3:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/73\">",
"      Nguyen NT, Slone JA, Nguyen XM, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 2009; 250:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/74\">",
"      Tice JA, Karliner L, Walsh J, et al. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008; 121:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/75\">",
"      Farrell TM, Haggerty SP, Overby DW, et al. Clinical application of laparoscopic bariatric surgery: an evidence-based review. Surg Endosc 2009; 23:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/76\">",
"      Prachand VN, Davee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI &gt; or =50 kg/m2) compared with gastric bypass. Ann Surg 2006; 244:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/77\">",
"      Hutter MM, Jones DB, M Riley S Jr, et al. Best practice updates for weight loss surgery data collection. Obesity (Silver Spring) 2009; 17:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/78\">",
"      Lim RB, Blackburn GL, Jones DB. Benchmarking best practices in weight loss surgery. Curr Probl Surg 2010; 47:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/79\">",
"      Wee CC, Pratt JS, Fanelli R, et al. Best practice updates for informed consent and patient education in weight loss surgery. Obesity (Silver Spring) 2009; 17:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/80\">",
"      Nguyen NT, Masoomi H, Laugenour K, et al. Predictive factors of mortality in bariatric surgery: data from the Nationwide Inpatient Sample. Surgery 2011; 150:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/81\">",
"      Wee CC, Jones DB, Davis RB, et al. Understanding patients' value of weight loss and expectations for bariatric surgery. Obes Surg 2006; 16:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/82\">",
"      Mason EE, Ito C. Gastric bypass. Ann Surg 1969; 170:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/83\">",
"      Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic Gastric Bypass, Roux-en-Y: Preliminary Report of Five Cases. Obes Surg 1994; 4:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/84\">",
"      Schauer P, Ikramuddin S, Hamad G, Gourash W. The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc 2003; 17:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/85\">",
"      Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology 2001; 120:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/86\">",
"      Guedea ME, Arribas del Amo D, Solanas JA, et al. Results of biliopancreatic diversion after five years. Obes Surg 2004; 14:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/87\">",
"      Mason EE. Vertical banded gastroplasty for obesity. Arch Surg 1982; 117:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/88\">",
"      Sugerman HJ, Kellum JM Jr, DeMaria EJ, Reines HD. Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity. Am J Surg 1996; 171:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/89\">",
"      Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/90\">",
"      Kellum JM, Kuemmerle JF, O'Dorisio TM, et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990; 211:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/91\">",
"      Brolin RE, LaMarca LB, Kenler HA, Cody RP. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg 2002; 6:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/92\">",
"      MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg 1993; 165:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/93\">",
"      Suter M, Jayet C, Jayet A. Vertical banded gastroplasty: long-term results comparing three different techniques. Obes Surg 2000; 10:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/94\">",
"      Moreno P, Alastru&eacute; A, Rull M, et al. Band erosion in patients who have undergone vertical banded gastroplasty: incidence and technical solutions. Arch Surg 1998; 133:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/95\">",
"      Romy S, Donadini A, Giusti V, Suter M. Roux-en-Y gastric bypass vs gastric banding for morbid obesity: a case-matched study of 442 patients. Arch Surg 2012; 147:460.",
"     </a>",
"    </li>",
"    <li>",
"     Andrews R, Oren JH, Yatco J, et al. Incidence and implications of abnormal glucose tolerance testing following gastric bypass. Proceedings of the Society of American Gastrointestinal and Endoscopic Surgeons, 2009 Apr 22-25; Phoenix, Arizona.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/97\">",
"      Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007; 92:4678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/98\">",
"      Gravante G, Araco A, Araco F, et al. Laparoscopic adjustable gastric bandings: a prospective randomized study of 400 operations performed with 2 different devices. Arch Surg 2007; 142:958.",
"     </a>",
"    </li>",
"    <li>",
"     Approval letter for LAP-BAND&reg; Adjustable Gastric Banding System (Allergan, Inc, Goleta, CA). Available from: file://www.accessdata.fda.gov/cdrh_docs/pdf/p000008s017a.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/100\">",
"      Belachew M, Legrand M, Vincenti V V, et al. Laparoscopic Placement of Adjustable Silicone Gastric Band in the Treatment of Morbid Obesity: How to Do It. Obes Surg 1995; 5:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/101\">",
"      O'Brien PE, Brown WA, Smith A, et al. Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity. Br J Surg 1999; 86:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/102\">",
"      O'Brien PE. Laparoscopic adjustable gastric banding: a real option for a real problem. ANZ J Surg 2003; 73:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/103\">",
"      O'Brien PE, Dixon JB. Lap-band: outcomes and results. J Laparoendosc Adv Surg Tech A 2003; 13:265.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Trial Summary of Safety and Effectiveness Data: The Lap-Band Adjustable Gastric Banding System (P000008). Available online at www.accessdata.fda.gov/cdrh_docs/pdf/P000008b.pdf (Accessed on June 17, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/105\">",
"      Sanchez H, Cabrera A, Cabrera K, et al. Laparoscopic Roux-en-Y gastric bypass as a revision procedure after restrictive bariatric surgery. Obes Surg 2008; 18:1539.",
"     </a>",
"    </li>",
"    <li>",
"     Schneider BE, Sanchez VM, Jones DB. How to implant the Laparoscopic Adjustable Gastric Band for morbid obesity. Contemporary Surgery 2004; 60:256. Available online at: www.jfponline.com/Pages.asp?AID=324 (Accessed on June 17, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/107\">",
"      Ren CJ, Horgan S, Ponce J. US experience with the LAP-BAND system. Am J Surg 2002; 184:46S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/108\">",
"      Spivak H, Anwar F, Burton S, et al. The Lap-Band system in the United States: one surgeon's experience with 271 patients. Surg Endosc 2004; 18:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/109\">",
"      Fox SR, Fox KM, Srikanth MS, Rumbaut R. The Lap-Band system in a North American population. Obes Surg 2003; 13:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/110\">",
"      O'Brien PE, MacDonald L, Anderson M, et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg 2013; 257:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/111\">",
"      Dixon JB, Chapman L, O'Brien P. Marked improvement in asthma after Lap-Band surgery for morbid obesity. Obes Surg 1999; 9:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/112\">",
"      Dixon JB, Schachter LM, O'Brien PE. Sleep disturbance and obesity: changes following surgically induced weight loss. Arch Intern Med 2001; 161:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/113\">",
"      Dixon JB, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med 2003; 20:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/114\">",
"      Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/115\">",
"      Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 2004; 14:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/116\">",
"      Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003; 13:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/117\">",
"      Baumann T, Kuesters S, Grueneberger J, et al. Time-resolved MRI after ingestion of liquids reveals motility changes after laparoscopic sleeve gastrectomy--preliminary results. Obes Surg 2011; 21:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/118\">",
"      Braghetto I, Davanzo C, Korn O, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg 2009; 19:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/119\">",
"      Felberbauer FX, Langer F, Shakeri-Manesch S, et al. Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers. Obes Surg 2008; 18:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/120\">",
"      Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg 2005; 15:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/121\">",
"      Gagner M, Deitel M, Kalberer TL, et al. The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009. Surg Obes Relat Dis 2009; 5:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/122\">",
"      Himpens J, Dapri G, Cadi&egrave;re GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006; 16:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/123\">",
"      Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011; 254:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/124\">",
"      Rubin M, Yehoshua RT, Stein M, et al. Laparoscopic sleeve gastrectomy with minimal morbidity. Early results in 120 morbidly obese patients. Obes Surg 2008; 18:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/125\">",
"      Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc 2007; 21:1810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/126\">",
"      Carter PR, LeBlanc KA, Hausmann MG, et al. Association between gastroesophageal reflux disease and laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 2011; 7:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/127\">",
"      Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996; 119:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/128\">",
"      Scopinaro N, Marinari GM, Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg 2002; 12:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/129\">",
"      Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22:947.",
"     </a>",
"    </li>",
"    <li>",
"     Lee, C, Feng, et al. Laparoscopic duodenal swtich and sleeve gastrectomy procedures. In: Surgical management of obesity, Buchwald, H, Cowan, et al.  (Eds), Saunders/Elsevier, Philadelphia 2007. p.267.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/131\">",
"      S&oslash;vik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med 2011; 155:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/132\">",
"      Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/133\">",
"      Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 2000; 10:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/134\">",
"      Baltasar A, Bou R, Mir&oacute; J, et al. Laparoscopic biliopancreatic diversion with duodenal switch: technique and initial experience. Obes Surg 2002; 12:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/135\">",
"      Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005; 61:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/136\">",
"      Roman S, Napol&eacute;on B, Mion F, et al. Intragastric balloon for \"non-morbid\" obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg 2004; 14:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/137\">",
"      Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004; 14:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/138\">",
"      Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg 2004; 14:671.",
"     </a>",
"    </li>",
"    <li>",
"     A Study of BioEnterics&reg; Intragastric Balloon (BIB&reg;) System to Assist in the Weight Management of Obese Subjects. Available online at: file://clinicaltrials.gov/ct2/show/NCT00730327 (Accessed on January 28, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/140\">",
"      Miller K, Pump A, Hell E. Vertical banded gastroplasty versus adjustable gastric banding: prospective long-term follow-up study. Surg Obes Relat Dis 2007; 3:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/141\">",
"      Balsiger BM, Poggio JL, Mai J, et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000; 4:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/142\">",
"      Nightengale ML, Sarr MG, Kelly KA, et al. Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity. Mayo Clin Proc 1991; 66:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/143\">",
"      Sugerman HJ, Londrey GL, Kellum JM, et al. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 1989; 157:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/144\">",
"      Benotti PN, Forse RA. Safety and long-term efficacy of revisional surgery in severe obesity. Am J Surg 1996; 172:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/145\">",
"      van Gemert WG, van Wersch MM, Greve JW, Soeters PB. Revisional surgery after failed vertical banded gastroplasty: restoration of vertical banded gastroplasty or conversion to gastric bypass. Obes Surg 1998; 8:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/146\">",
"      Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 2008; 68:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/147\">",
"      Payne JH, DeWind LT. Surgical treatment of obesity. Am J Surg 1969; 118:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/148\">",
"      Halverson JD, Wise L, Wazna MF, Ballinger WF. Jejunoileal bypass for morbid obesity. A critical appraisal. Am J Med 1978; 64:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/149\">",
"      Clayman RV, Williams RD. Oxalate urolithiasis following jejunoileal bypass. Surg Clin North Am 1979; 59:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/150\">",
"      Kroyer JM, Talbert WM Jr. Morphologic liver changes in intestinal bypass patients. Am J Surg 1980; 139:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/151\">",
"      Griffen WO Jr, Bivins BA, Bell RM. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet 1983; 157:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/152\">",
"      Deitel M, Shahi B, Anand PK, et al. Long-term Outcome in a Series of Jejunoileal Bypass Patients. Obes Surg 1993; 3:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/31/33274/abstract/153\">",
"      Balsiger BM, Murr MM, Mai J, Sarr MG. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass. J Gastrointest Surg 2000; 4:276.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 586 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-197.136.42.3-858ECED34C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33274=[""].join("\n");
var outline_f32_31_33274=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BODY MASS INDEX",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF WEIGHT LOSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Restriction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Malabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Combination of restriction and malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EFFECTIVENESS OF BARIATRIC SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Reduction of comorbidities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H297382\">",
"      Reduction in mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Surgery compared to medical treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Treatment for type 2 diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21798476\">",
"      Liver disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H297556\">",
"      Transplant patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H297563\">",
"      ACCREDITATION OF BARIATRIC PROGRAMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CHOOSING A PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      BARIATRIC SURGICAL PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Roux-en-Y gastric bypass",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Minimally invasive technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Weight loss mechanism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Laparoscopic adjustable gastric banding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Sleeve gastrectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Biliopancreatic diversion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H772598659\">",
"      Duodenal switch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Biliopancreatic diversion with duodenal switch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Intragastric balloon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Vertical banded gastroplasty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Endoluminal vertical gastroplasty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Jejunoileal bypass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Liposuction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/586\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/586|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?5/15/5364\" title=\"figure 1\">",
"      Retrocolic Roux-en-Y gastric bypass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/35/33329\" title=\"figure 2\">",
"      Roux en Y gastric bypass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/54/22368\" title=\"figure 3\">",
"      Adjustable gastric band",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/37/39519\" title=\"figure 4\">",
"      Gastric band adjustment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/40/36480\" title=\"figure 5\">",
"      Sleeve gastrectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/53/19284\" title=\"figure 6\">",
"      Biliopancreatic diversion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/33/19987\" title=\"figure 7\">",
"      Duodenal switch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/27/43455\" title=\"figure 8\">",
"      Intragastric balloon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/28/36303\" title=\"figure 9\">",
"      Vertical band gastroplasty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/34/24098\" title=\"figure 10\">",
"      Jejunoileal bypass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/586|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/40/30347\" title=\"table 1\">",
"      Health risks from obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/55/4987\" title=\"table 2\">",
"      Types of bariatric procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/25/1435\" title=\"table 3\">",
"      Indications bariatric surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?39/41/40593?source=related_link\" title=\"calculator 1\">",
"      Calculator: Body mass index (BMI; Quetelet's index)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=related_link\">",
"      Complications of bariatric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16758?source=related_link\">",
"      Ghrelin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38298?source=related_link\">",
"      Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=related_link\">",
"      Management of Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/19/28986?source=related_link\">",
"      Management of persistent hyperglycemia in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26362?source=related_link\">",
"      Medical management of patients after bariatric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/25/15770?source=related_link\">",
"      Model for End-stage Liver Disease (MELD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23882?source=related_link\">",
"      Natural history and management of nonalcoholic fatty liver disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/59/17337?source=related_link\">",
"      Overview of the complications, prognosis, and management of cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/45/13016?source=related_link\">",
"      Overview of therapy for obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/38/13929?source=related_link\">",
"      Pathogenesis of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/37/9811?source=related_link\">",
"      Patient information: Weight loss surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/31/14835?source=related_link\">",
"      Patient information: Weight loss surgery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/5/33876?source=related_link\">",
"      Patient information: Weight loss treatments (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42905?source=related_link\">",
"      Surgical management of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_31_33275="Lugano staging GI lymphoma";
var content_f32_31_33275=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F65686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F65686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Lugano staging system for gastrointestinal lymphomas",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <strong>",
"         Stage I",
"        </strong>",
"        - The tumor is confined to the gastrointestinal tract. It can be a single primary lesion or multiple, noncontiguous lesions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Stage II",
"        </strong>",
"        - The tumor extends into the abdomen. This is further subdivided based upon the location of nodal involvement:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Stage II",
"        <sub>",
"         1",
"        </sub>",
"        : Involvement of local nodes (paragastric nodes for gastric lymphoma or para-intestinal nodes for intestinal lymphoma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Stage II",
"        <sub>",
"         2",
"        </sub>",
"        : Involvement of distant nodes (para-aortic, para-caval, pelvic, or inguinal nodes for most tumors; mesenteric nodes in the case of intestinal lymphoma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Stage IIE: The tumor penetrates the serosa to involve adjacent organs or tissues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Stage III",
"        </strong>",
"        - There is no stage III disease in this system.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Stage IV",
"        </strong>",
"        - There is disseminated extranodal involvement or concomitant supra-diaphragmatic nodal involvement.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classification of gastrointestinal tract lymphoma. Ann Oncol 1994; 5:397. Copyright &copy; 1994 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33275=[""].join("\n");
var outline_f32_31_33275=null;
var title_f32_31_33276="Guidelines for optimizing heat acclimatization";
var content_f32_31_33276=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82776&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82776&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Guidelines for optimizing heat acclimatization",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td colspan=\"2\">",
"        Acclimatization should be performed gradually over 10-14 consecutive days",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Environment",
"       </td>",
"       <td>",
"        Reflects the environment that will be encountered during goal activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Warm or hot (WBGT &gt;26&deg;C)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Relative humidity reflects the humidity that will be encountered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If necessary environmental conditions not present, add clothing or exercise during hottest/most humid part of the day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Exercise session",
"       </td>",
"       <td>",
"        Duration: &gt;60 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Type: aerobic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intensity: moderate intensity (should progress from 60-80 percent age-predicted maximum heart rate)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frequency: one session per day (may progress to two sessions per day alternating with a single session day)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Hydration",
"       </td>",
"       <td>",
"        Urine specific gravity: &lt;1.020",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urine osmolality: &lt;700",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urine color: &lt;3 (using 8 color scale)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"7\">",
"        Safety",
"       </td>",
"       <td>",
"        Monitor temperature with rectal or gastrointestinal thermistor (&lt;40&deg;C)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monitor athlete for signs&nbsp;and symptoms of heat illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monitor heart rate for increased intensity (&gt;80 percent age-predicted maximum)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid interval training at race speeds (may be&nbsp;performed separately in a cooler environment)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calculate sweat rate: pre-exercise nude body mass (kg)&nbsp;- post-exercise nude body mass (kg) + fluid ingested (L) per exercise time (hour) = sweat rate (L/hour)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Keep athlete well hydrated before and during exercise (&lt;2 percent dehydrated)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Training intensity should correspond with fitness level",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Daanen HAM, Jonkman AG, Layden JD, et al. Optimising the acquisition and rentention of heat acclimation. Int J Sports Med 2011; 32:822-828.",
"      </li>",
"      <li>",
"       Cheung SS. Heat Stress. Advanced Environmental Exercise Physiology. Champaign, IL:Human Kinetics; 2010.",
"      </li>",
"      <li>",
"       Kuennen M, Gillum T, Dokladny K, et al. Thermotolerance and heat acclimation may share a common mechanism in humans. Am J Physiol Regul Integr Comp Physiol 2011; 301: R524-R533.",
"      </li>",
"      <li>",
"       Armstrong LE, Maresh CM, Castellani JW, et al. Urineary indices of hydration status. Int J Sport Nutr 1992; 4:265.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33276=[""].join("\n");
var outline_f32_31_33276=null;
var title_f32_31_33277="Calcium channel blocker poisoning - Rapid overview";
var content_f32_31_33277=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63193&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63193&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Calcium channel blocker poisoning: Rapid overview",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"        </span>",
"        <a href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\" target=\"_blank\">",
"         www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"        </a>",
"        <span style=\"color: #ff0000;\">",
"         ).",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypotension and bradycardia are prominent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrocardiogram may show PR prolongation or any bradydysrhythmia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patients with a significant calcium channel blocker (CCB) ingestion can deteriorate rapidly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnostic evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Assays for CCBs are not routinely available",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnosis depends on the history and clinical presentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Differential diagnosis for unexplained bradycardia includes toxicity from medications including CCBs, beta-blockers, clonidine, and digoxin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Structural cardiac disease and active myocardial ischemia must be excluded",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Assess and stabilize airway, breathing, and circulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        For patients with severe calcium channel blocker (CCB) poisoning (eg, profound hypotension refractory to crystalloid boluses and atropine), give ALL of the following: calcium salts, glucagon, high dose insulin and dextrose, vasopressor, and lipid emulsion therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        For patients with mild CCB poisoning, give the following treatments in succession based upon patient response (see topic text for details): IV crystalloid, atropine, calcium salts, glucagon, high dose insulin and dextrose, vasopressor, and lipid emulsion therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Initiate treatment for hypotension and bradycardia, if present:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intravenous crystalloid (hypotension): isotonic saline 500 to 1000 mL boluses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Atropine (bradycardia): 1 mg IV; may repeat for 3 total doses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Intravenous calcium (hypotension and/or bradycardia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Bolus therapy:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Calcium chloride - 10 to 20 mL of 10 percent solution (via central venous access if possible)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Calcium gluconate - 30 to 60 mL of 10 percent solution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Continuous infusion of 0.5 meq calcium/kg per hour",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Monitor serum calcium and ECG for evidence of hypercalcemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Glucagon (bradycardia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Bolus therapy:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        1-5 mg IV push, may repeat up to 15 mg total",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Continuous infusion:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Determine bolus amount needed to obtain response; give this \"response dose\" every hour as continuous infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Vasopressor support (hypotension)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Norepinephrine: begin 2 mcg/minute IV, titrate rapidly to systolic blood pressure 100 mmHg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Hyperinsulinemia with euglycemia (hypotension)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Bolus therapy:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Regular insulin 1 Unit/kg IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Dextrose 25-50 grams IV; repeat for hypoglycemia; give potassium for hypokalemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Maintenance infusions:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Regular insulin: start infusion at 0.5 Units/kg per hour IV; titrate upwards until hypotension corrected or maximum dose of 2 Units/kg per hour reached",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Dextrose 0.5 grams/kg per hour; titrate to euglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Gastrointestinal decontamination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Activated charcoal: 1 gram/kg up to 50 grams",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Whole bowel irrigation: 2 L/hour by mouth; for extended-release preparations only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Consider the following therapies if the above measures fail:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Transvenous cardiac pacing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intraaortic balloon pump",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cardiopulmonary bypass",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extracorporeal membrane oxygenation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33277=[""].join("\n");
var outline_f32_31_33277=null;
var title_f32_31_33278="Wrist hypermobility";
var content_f32_31_33278=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F61525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F61525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Joint laxity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 207px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Laxity of the wrist allows approximation of the thumb to the patient's ipsilateral forearm. Joint laxity is a crucial feature of the hypermobility syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Sheon RP, Moskowitz RW, Goldberg VM. Soft Tissue Rheumatic Pain: Recognition, Management, Prevention, 3rd ed, Williams &amp; Wilkins, Baltimore 1996.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33278=[""].join("\n");
var outline_f32_31_33278=null;
var title_f32_31_33279="Greenstick and complete fracture";
var content_f32_31_33279=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F58106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F58106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Midshaft forearm fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    6-year-old with unstable midshaft radius and ulna fracture with significant dorsal displacement and volar angulation. The radius fracture is a greenstick with 30 degrees of angulation. The ulna fracture is complete with angulation and displacement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paula Schweich, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_31_33279=[""].join("\n");
var outline_f32_31_33279=null;
